Qifu Technology Announces Third Quarter 2024 Unaudited Financial Results and Launches A New US$450 Million Share Repurchase Plan for 2025
SHANGHAI, China, Nov. 19, 2024 (GLOBE NEWSWIRE) — Qifu Technology, Inc. QFIN HKEx: 3660)) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2024 and launched a new US$450 million share repurchase plan for 2025.
Third Quarter 2024 Business Highlights
- As of September 30, 2024, our platform has connected 162 financial institutional partners and 254.3 million consumers*1 with potential credit needs, cumulatively, an increase of 11.6% from 227.9 million a year ago.
- Cumulative users with approved credit lines*2 were 55.2 million as of September 30, 2024, an increase of 12.2% from 49.2 million as of September 30, 2023.
- Cumulative borrowers with successful drawdown, including repeat borrowers was 33.1 million as of September 30, 2024, an increase of 12.6% from 29.4 million as of September 30, 2023.
- In the third quarter of 2024, financial institutional partners originated 23,042,303 loans*3 through our platform.
- Total facilitation and origination loan volume*4 of ongoing services reached RMB82,436 million, a decrease of 14.9% from RMB96,923 million in the same period of 2023 and an increase of 13.1% from RMB72,864 million in the prior quarter. RMB45,396 million of such loan volume was under capital-light model, Intelligence Credit Engine (“ICE”) and total technology solutions*5, representing 55.1% of the total, an increase of 4.7% from RMB43,353 million in the same period of 2023 and an increase of 15.4% from RMB39,344 million in the prior quarter.
- Loan facilitation volume of intended discontinued service*6 reached RMB17,145 million, a decrease of 34.6% from RMB26,226 million in the same period of 2023 and a decrease of 24.0% from RMB22,561 million in the prior quarter.
- Total outstanding loan balance*7 of ongoing services was RMB127,727 million as of September 30, 2024, a decrease of 13.3% from RMB147,237 million as of September 30, 2023 and an increase of 3.4% from RMB123,551 million as of June 30, 2024. RMB74,078 million of such loan balance was under capital-light model, “ICE” and total technology solutions*8, a decrease of 0.5% from RMB74,421 million as of September 30, 2023 and an increase of 6.4% from RMB69,589 million as of June 30, 2024.
- Outstanding loan balance of intended discontinued service*6 was RMB31,901 million as of September 30, 2024, a decrease of 23.8% from RMB41,863 million as of September 30, 2023 and a decrease of 6.8% from RMB34,227 million as of June 30, 2024.
- The weighted average contractual tenor of loans originated by financial institutions across our platform in the third quarter of 2024 was approximately 10.12 months, compared with 11.23 months in the same period of 2023.
- 90 day+ delinquency rate*9 of loans originated by financial institutions across our platform was 2.72% as of September 30, 2024.
- Repeat borrower contribution*10 of loans originated by financial institutions across our platform for the third quarter of 2024 was 93.8%.
1 Refers to cumulative registered users across our platform.
2 “Cumulative users with approved credit lines” refers to the total number of users who had submitted their credit applications and were approved with a credit line at the end of each period.
3 Including 3,298,567 loans across “V-pocket”, and 19,743,736 loans across other products.
4 Refers to the total principal amount of loans facilitated and originated during the given period.
5 “ICE” is an open platform primarily on our “Qifu Jietiao” APP (previously known as “360 Jietiao”), we match borrowers and financial institutions through big data and cloud computing technology on “ICE”, and provide pre-loan investigation report of borrowers. For loans facilitated through “ICE”, the Company does not bear principal risk. Loan facilitation volume through “ICE” was RMB 29,635 million in the third quarter of 2024.
Under total technology solutions, we have been offering end-to-end technology solutions to financial institutions based on on-premise deployment, SaaS or hybrid model since 2023. Loan facilitation volume through total technology solutions was RMB761 million in the third quarter of 2024.
6 In 2021, we started to offer financial institutions on-premise deployed, modular risk management SaaS, which helps financial institution partners improve credit assessment results. We further began to offer end-to-end technology solutions to financial institutions based on on-premise deployment, SaaS or hybrid model in 2023, which we refer to as total technology solutions. These foregoing services combined were previously referred to as other technology solutions. However, as the risk management SaaS service only generated marginal returns and had little potential for up selling, we intend to gradually discontinue it by the end of 2024. The gradual discontinuation of the service is not expected to have a material impact on our overall business, financial condition, and results of operations.
7 “Total outstanding loan balance” refers to the total amount of principal outstanding for loans facilitated and originated at the end of each period, excluding loans delinquent for more than 180 days.
8 As of September 30, 2024, outstanding loan balance was RMB42,898 million for “ICE” and RMB1,544 million for total technology solutions.
9 “90 day+ delinquency rate” refers to the outstanding principal balance of on- and off-balance sheet loans that were 91 to 180 calendar days past due as a percentage of the total outstanding principal balance of on- and off-balance sheet loans across our platform as of a specific date. Loans that are charged-off and loans under “ICE” and total technology solutions are not included in the delinquency rate calculation.
10 “Repeat borrower contribution” for a given period refers to (i) the principal amount of loans borrowed during that period by borrowers who had historically made at least one successful drawdown, divided by (ii) the total loan facilitation and origination volume through our platform during that period.
Third Quarter 2024 Financial Highlights
- Total net revenue was RMB4,370.2 million (US$622.7 million), compared to RMB 4,281.0 million in the same period of 2023.
- Income from operations was RMB2,289.2 million (US$326.2 million), compared to RMB 1,388.9 million in the same period of 2023.
- Non-GAAP*11 income from operations was RMB2,315.5 million (US$330.0 million), compared to RMB 1,432.2 million in the same period of 2023.
- Operating margin was 52.4%. Non-GAAP operating margin was 53.0%.
- Net income was RMB1,798.8 million (US$256.3 million), compared to RMB 1,137.7 million in the same period of 2023.
- Non-GAAP net income was RMB1,825.1 million (US$260.1 million), compared to RMB 1,181.0 million in the same period of 2023.
- Net income margin was 41.2%. Non-GAAP net income margin was 41.8%.
- Net income per fully diluted American depositary share (“ADS”) was RMB12.18 (US$1.74), compared to RMB6.94 in the same period of 2023.
- Non-GAAP net income per fully diluted ADS was RMB12.35 (US$1.76), compared to RMB7.20 in the same period of 2023.
11 Non-GAAP income from operations, Non-GAAP net income, Non-GAAP operating margin, Non-GAAP net income margin and Non-GAAP net income per fully diluted ADS are Non-GAAP financial measures. For more information on these Non-GAAP financial measures, please see the section of “Use of Non-GAAP Financial Measures Statement” and the table captioned “Unaudited Reconciliations of GAAP and Non-GAAP Results” set forth at the end of this press release.
Mr. Haisheng Wu, Chief Executive Officer and Director of Qifu Technology, commented, “We are very pleased to deliver a strong quarter of financial results in a still challenging macro environment with some tentative sign of increasing users’ activities late in the quarter. We continued to make noticeable progress in key areas of our operations and achieved better efficiency and enhanced returns.
During the quarter, we saw continued improvement in net take rates with the help of improving risks and lowering funding costs. Non-credit risk bearing loans for ongoing services accounted for nearly 55% of total volume. In the third quarter, we further reduced unit costs for user acquisition through more efficient and diversified user acquisition channels. Meanwhile, in an overall easing funding environment, we continued to strengthen our relationship with financial institution partners and further reduced overall funding costs to another historic low.
While we are encouraged by recent release of stimulus economic policies, it may still take a while to see the actual impact to the overall consumer demand and consumption behavior. Looking ahead, we intend to continue to take a disciplined risk management approach despite improved asset quality and tentatively uptick in user activities. With our consistent execution, we believe we are well positioned to capture long-term opportunities by building a comprehensive credit-tech platform that offers differentiate products and services to users and financial institution partners based on their respective credit profiles and risk preferences.”
“We are excited to report a set of strong financial results in the quarter. Total net revenue was RMB4.37 billion and Non-GAAP net income was RMB1.83 billion for the third quarter,” Mr. Alex Xu, Chief Financial Officer, commented. “At the end of the third quarter, our total cash and cash equivalent*12 was approximately RMB9.77 billion, and we generated approximately RMB2.37 billion cash from operations. During the quarter, we continued to execute the US$350 million share repurchase program with meaningful progress. The newly approved US$450 million share repurchase program for 2025 further demonstrates our strong commitment to sustainable shareholder returns through dividend and share repurchases.”
Mr. Yan Zheng, Chief Risk Officer, added, “We experienced further improvement in overall risk metrics of our loan book in the third quarter as we continued to take a prudent approach in managing risks. Among key leading indicators, Day-1 delinquency rate*13 was 4.6%, and 30-day collection rate*14 was approximately 87.4%. The 30-day collection rates reached its best levels in the past three years. As we remain vigilant in risk management under current macro environment, we expect to see relatively stable overall risk performance in the coming quarters.”
12 Including “Cash and cash equivalents”, “Restricted cash”, “Security deposit prepaid to third-party guarantee companies” and “Short-term investments”.
13 “Day-1 delinquency rate” is defined as (i) the total amount of principal that became overdue as of a specified date, divided by (ii) the total amount of principal that was due for repayment as of such specified date.
14 “30-day collection rate” is defined as (i) the amount of principal that was repaid in one month among the total amount of principal that became overdue as of a specified date, divided by (ii) the total amount of principal that became overdue as of such specified date.
Third Quarter 2024 Financial Results
Total net revenue was RMB4,370.2 million (US$622.7 million), compared to RMB4,281.0 million in the same period of 2023, and RMB4,160.1 million in the prior quarter.
Net revenue from Credit Driven Services was RMB 2,901.0 million (US$413.4 million), compared to RMB3,071.0 million in the same period of 2023, and RMB2,912.2 million in the prior quarter.
Loan facilitation and servicing fees-capital heavy were RMB258.7 million (US$36.9 million), compared to RMB479.2 million in the same period of 2023 and RMB151.1 million in the prior quarter. The year-over-year decrease was primarily due to the decline in capital-heavy loan facilitation volume, and the sequential increase mainly due to increasing capital-heavy loan facilitation volume and lower funding cost for capital-heavy loan facilitation.
Financing income*15 was RMB1,744.1 million (US$248.5 million), compared to RMB1,369.9 million in the same period of 2023 and RMB1,690.1 million in the prior quarter. The year-over-year increase was primarily due to the growth in outstanding balance of the on-balance-sheet loans.
Revenue from releasing of guarantee liabilities was RMB794.6 million (US$113.2 million), compared to RMB1,165.7 million in the same period of 2023, and RMB972.6 million in the prior quarter. The year-over-year and sequential decreases were mainly due to decreases in the average outstanding balance of off-balance-sheet capital-heavy loans during the period.
Other services fees were RMB103.7 million (US$14.8 million), compared to RMB56.1 million in the same period of 2023, and RMB98.4 million in the prior quarter. The year-over-year and sequential increases were mainly due to the increases in late payment fees under the capital-heavy model.
Net revenue from Platform Services was RMB1,469.1 million (US$209.3 million), compared to RMB1,210.1 million in the same period of 2023 and RMB1,247.9 million in the prior quarter.
Loan facilitation and servicing fees-capital light were RMB574.6 million (US$81.9 million), compared to RMB863.9 million in the same period of 2023 and RMB524.4 million in the prior quarter. The year-over-year decrease was mainly due to a lower capital-light loan facilitation volume.
Referral services fees were RMB763.1 million (US$108.7 million), compared to RMB234.2 million in the same period of 2023 and RMB623.5 million in the prior quarter. The year-over-year and sequential increases were mainly due to the increases in the loan facilitation volume through ICE.
Other services fees were RMB131.4 million (US$18.7 million), compared to RMB112.0 million in the same period of 2023 and RMB100.0 million in the prior quarter.
Total operating costs and expenses were RMB2,081.0 million (US$296.5 million), compared to RMB2,892.2 million in the same period of 2023 and RMB2,175.1 million in the prior quarter.
Facilitation, origination and servicing expenses were RMB707.9 million (US$100.9 million), compared to RMB639.8 million in the same period of 2023 and RMB722.2 million in the prior quarter. The year-over-year increase was primarily due to higher collection fees.
Funding costs were RMB146.8 million (US$20.9 million), compared to RMB160.2 million in the same period of 2023 and RMB161.3 million in the prior quarter. The year-over-year decrease was mainly due to the lower average cost of ABS and trusts. The sequential decrease was mainly due to the decline in funding from ABS and trusts and lower average costs.
Sales and marketing expenses were RMB419.9 million (US$59.8 million), compared to RMB529.6 million in the same period of 2023 and RMB366.4 million in the prior quarter. The year-over-year decrease was mainly due to a more prudent customer acquisition approach. The sequential increase was primarily due to an increased number of customers acquired, offset by a lower unit customer acquisition cost.
General and administrative expenses were RMB92.0 million (US$13.1 million), compared to RMB95.4 million in the same period of 2023 and RMB95.1 million in the prior quarter.
Provision for loans receivable was RMB477.5 million (US$68.0 million), compared to RMB509.0 million in the same period of 2023 and RMB849.5 million in the prior quarter. The year-over-year decrease mainly reflected the Company’s consistent approach in assessing provisions commensurate with its underlying loan profile. The sequential decrease was mainly due to the decrease in loan origination volume of on-balance-sheet loans and a larger reversal of prior quarters’ provision because of improving asset quality.
Provision for financial assets receivable was RMB64.4 million (US$9.2 million), compared to RMB86.9 million in the same period of 2023 and RMB70.2 million in the prior quarter. The year-over-year and sequential decreases mainly reflected the Company’s consistent approach in assessing provisions commensurate with its underlying loan profile. In addition, the year-over-year decrease was due to the decline in loan facilitation volume of off-balance-sheet loans.
Provision for accounts receivable and contract assets was RMB108.8 million (US$15.5 million), compared to RMB39.7 million in the same period of 2023 and RMB123.8 million in the prior quarter. The year-over-year and sequential changes reflected the Company’s consistent approach in assessing provisions commensurate with its underlying loan profile.
Provision for contingent liability was RMB63.6 million (US$9.1 million), compared to RMB831.6 million in the same period of 2023 and RMB-213.3 million in the prior quarter. The year-over-year and sequential changes reflected the Company’s consistent approach in assessing provisions commensurate with its underlying loan profile as well as the change in capital-heavy loan facilitation volume.
Income from operations was RMB2,289.2 million (US$326.2 million), compared to RMB1,388.9 million in the same period of 2023 and RMB1,985.0 million in the prior quarter.
Non-GAAP income from operations was RMB2,315.5 million (US$330.0 million), compared to RMB1,432.2 million in the same period of 2023 and RMB2,021.9 million in the prior quarter.
Operating margin was 52.4%. Non-GAAP operating margin was 53.0%.
Income before income tax expense was RMB2,356.9 million (US$335.9 million), compared to RMB1,478.1 million in the same period of 2023 and RMB2,076.6 million in the prior quarter.
Net income was RMB1,798.8 million (US$256.3 million), compared to RMB1,137.7 million in the same period of 2023 and RMB1,376.5 million in the prior quarter.
Non-GAAP net income was RMB1,825.1 million (US$260.1 million), compared to RMB1,181.0 million in the same period of 2023 and RMB1,413.4 million in the prior quarter.
Net income margin was 41.2%. Non-GAAP net income margin was 41.8%.
Net income attributed to the Company was RMB1,802.9 million (US$256.9 million), compared to RMB1,142.0 million in the same period of 2023 and RMB1,380.5 million in the prior quarter.
Non-GAAP net income attributed to the Company was RMB1,829.2 million (US$260.7 million), compared to RMB1,185.3 million in the same period of 2023 and RMB1,417.4 million in the prior quarter.
Net income per fully diluted ADS was RMB12.18 (US$1.74).
Non-GAAP net income per fully diluted ADS was RMB12.35 (US$1.76).
Weighted average basic ADS used in calculating GAAP net income per ADS was 145.30 million.
Weighted average diluted ADS used in calculating GAAP and non-GAAP net income per ADS was 148.10 million.
15 “Financing income” is generated from loans facilitated through the Company’s platform funded by the consolidated trusts and Fuzhou Microcredit, which charge fees and interests from borrowers.
30 Day+ Delinquency Rate by Vintage and 180 Day+ Delinquency Rate by Vintage
The following charts and tables display the historical cumulative 30 day+ delinquency rates by loan facilitation and origination vintage and 180 day+ delinquency rates by loan facilitation and origination vintage for all loans facilitated and originated through the Company’s platform. Loans under “ICE” and total technology solutions are not included in the 30 day+ charts and the 180 day+ charts:
http://ml.globenewswire.com/Resource/Download/34f83b73-48a7-41be-a668-6e743c1d297c
http://ml.globenewswire.com/Resource/Download/1360a84d-f015-42f7-8863-25fc8d82115e
Update on Share Repurchase Plan of 2024
On March 12, 2024, the Company’s board of directors approved a share repurchase plan whereby the Company is authorized to repurchase its ADSs or Class A ordinary shares with an aggregate value of up to US$350 million during the 12-month period from April 1, 2024.
As of November 19, 2024, the Company had in aggregate purchased approximately 13.7 million ADSs in the open market for a total amount of approximately US$298 million (inclusive of commissions) at an average price of US$21.7 per ADS pursuant to the share repurchase plan.
New US$450 Million Share Repurchase Plan of 2025
On November 19, 2024, the Company’s board of directors approved a new share repurchase plan whereby the Company is authorized to repurchase up to US$450 million worth of its ADSs or Class A ordinary shares over the next 12 months starting from January 1, 2025. The share repurchases may be effected from time to time on the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and will be implemented in accordance with applicable rules and regulations.
Business Outlook
As macro-economic uncertainties persist, the Company intends to maintain a prudent approach in its business planning. Management will continue to focus on enhancing efficiency of the Company’s operations. As such, for the fourth quarter of 2024, the Company expects to generate a net income between RMB1.75 billion and RMB1.85 billion and a non-GAAP net income*16 between RMB1.80 billion and RMB1.90 billion, representing a year-on-year growth between 57% and 65%. This outlook reflects the Company’s current and preliminary views, which is subject to material changes.
16 Non-GAAP net income represents net income excluding share-based compensation expenses.
Conference Call Preregistration
Qifu Technology’s management team will host an earnings conference call at 7:30 PM U.S. Eastern Time on Tuesday, November 19, 2024 (8:30 AM Beijing Time on Wednesday, November 20, 2024).
All participants wishing to join the conference call must pre-register online using the link provided below.
Registration Link: https://register.vevent.com/register/BI019bc78618c84e7184e794d691cfdb5b
Upon registration, each participant will receive details for the conference call, including dial-in numbers and a unique access PIN. Please dial in 10 minutes before the call is scheduled to begin.
Additionally, a live and archived webcast of the conference call will be available on the Investor Relations section of the Company’s website at http://ir.qifu.tech.
About Qifu Technology
Qifu Technology is a leading Credit-Tech platform in China that provides a comprehensive suite of technology services to assist financial institutions and consumers and SMEs in the loan lifecycle, ranging from borrower acquisition, preliminary credit assessment, fund matching and post-facilitation services. The Company is dedicated to making credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions.
For more information, please visit: https://ir.qifu.tech.
Use of Non-GAAP Financial Measures Statement
To supplement our financial results presented in accordance with U.S. GAAP, we use Non-GAAP financial measure, which is adjusted from results based on U.S. GAAP to exclude share-based compensation expenses. Reconciliations of our Non-GAAP financial measures to our U.S. GAAP financial measures are set forth in tables at the end of this earnings release, which provide more details on the Non-GAAP financial measures.
We use Non-GAAP income from operation, Non-GAAP operating margin, Non-GAAP net income, Non-GAAP net income margin, Non-GAAP net income attributed to the Company and Non-GAAP net income per fully diluted ADS in evaluating our operating results and for financial and operational decision-making purposes. Non-GAAP income from operation represents income from operation excluding share-based compensation expenses. Non-GAAP operating margin is equal to Non-GAAP income from operation divided by total net revenue. Non-GAAP net income represents net income excluding share-based compensation expenses. Non-GAAP net income margin is equal to Non-GAAP net income divided by total net revenue. Non-GAAP net income attributed to the Company represents net income attributed to the Company excluding share-based compensation expenses. Non-GAAP net income per fully diluted ADS represents net income excluding share-based compensation expenses per fully diluted ADS. Such adjustments have no impact on income tax. We believe that Non-GAAP income from operation, Non-GAAP operating margin, Non-GAAP net income, Non-GAAP net income margin, Non-GAAP net income attributed to the Company and Non-GAAP net income per fully diluted ADS help identify underlying trends in our business that could otherwise be distorted by the effect of certain expenses that we include in results based on U.S. GAAP. We believe that Non-GAAP income from operation and Non-GAAP net income provide useful information about our operating results, enhance the overall understanding of our past performance and future prospects and allow for greater visibility with respect to key metrics used by our management in its financial and operational decision-making. Our Non-GAAP financial information should be considered in addition to results prepared in accordance with U.S. GAAP, but should not be considered a substitute for or superior to U.S. GAAP results. In addition, our calculation of Non-GAAP financial information may be different from the calculation used by other companies, and therefore comparability may be limited.
Exchange Rate Information
This announcement contains translations of certain RMB amounts into U.S. dollars at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars are made at a rate of RMB 7.0176 to US$1.00, the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of September 30, 2024.
Safe Harbor Statement
Any forward-looking statements contained in this announcement are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the business outlook and quotations from management in this announcement, as well as the Company’s strategic and operational plans, contain forward-looking statements. Qifu Technology may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (“SEC”), in announcements made on the website of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including the Company’s business outlook, beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, which factors include but not limited to the following: the Company’s growth strategies, the Company’s cooperation with 360 Group, changes in laws, rules and regulatory environments, the recognition of the Company’s brand, market acceptance of the Company’s products and services, trends and developments in the credit-tech industry, governmental policies relating to the credit-tech industry, general economic conditions in China and around the globe, and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks and uncertainties is included in Qifu Technology’s filings with the SEC and announcements on the website of the Hong Kong Stock Exchange. All information provided in this press release is as of the date of this press release, and Qifu Technology does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For more information, please contact:
Qifu Technology
E-mail: ir@360shuke.com
Unaudited Condensed Consolidated Balance Sheets (Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“USD”) except for number of shares and per share data, or otherwise noted) |
|||
December 31, | September 30, | September 30, | |
2023 | 2024 | 2024 | |
RMB | RMB | USD | |
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | 4,177,890 | 4,288,460 | 611,101 |
Restricted cash | 3,381,107 | 2,253,397 | 321,107 |
Short term investments | 15,000 | 3,120,158 | 444,619 |
Security deposit prepaid to third-party guarantee companies | 207,071 | 108,670 | 15,485 |
Funds receivable from third party payment service providers | 1,603,419 | 771,847 | 109,987 |
Accounts receivable and contract assets, net | 2,909,245 | 2,183,030 | 311,079 |
Financial assets receivable, net | 2,522,543 | 1,410,934 | 201,056 |
Amounts due from related parties | 45,346 | 17,124 | 2,440 |
Loans receivable, net | 24,604,487 | 26,317,013 | 3,750,144 |
Prepaid expenses and other assets | 329,920 | 1,188,059 | 169,297 |
Total current assets | 39,796,028 | 41,658,692 | 5,936,315 |
Non-current assets: | |||
Accounts receivable and contract assets, net-noncurrent | 146,995 | 34,954 | 4,981 |
Financial assets receivable, net-noncurrent | 596,330 | 193,252 | 27,538 |
Amounts due from related parties | 4,240 | 106 | 15 |
Loans receivable, net-noncurrent | 2,898,005 | 2,743,839 | 390,994 |
Property and equipment, net | 231,221 | 331,200 | 47,196 |
Land use rights, net | 977,461 | 961,919 | 137,072 |
Intangible assets | 13,443 | 11,828 | 1,685 |
Goodwill | 41,210 | 42,368 | 6,037 |
Deferred tax assets | 1,067,738 | 964,505 | 137,441 |
Other non-current assets | 45,901 | 45,852 | 6,534 |
Total non-current assets | 6,022,544 | 5,329,823 | 759,493 |
TOTAL ASSETS | 45,818,572 | 46,988,515 | 6,695,808 |
LIABILITIES AND EQUITY | |||
Current liabilities: | |||
Payable to investors of the consolidated trusts-current | 8,942,291 | 7,643,597 | 1,089,204 |
Accrued expenses and other current liabilities | 2,016,039 | 2,678,610 | 381,699 |
Amounts due to related parties | 80,376 | 38,780 | 5,526 |
Short term loans | 798,586 | 1,043,404 | 148,684 |
Guarantee liabilities-stand ready | 3,949,601 | 2,266,859 | 323,025 |
Guarantee liabilities-contingent | 3,207,264 | 1,654,924 | 235,825 |
Income tax payable | 742,210 | 839,403 | 119,614 |
Other tax payable | 163,252 | 93,753 | 13,360 |
Total current liabilities | 19,899,619 | 16,259,330 | 2,316,937 |
Non-current liabilities: | |||
Deferred tax liabilities | 224,823 | 503,675 | 71,773 |
Payable to investors of the consolidated trusts-noncurrent | 3,581,800 | 7,093,800 | 1,010,858 |
Other long-term liabilities | 102,473 | 232,290 | 33,101 |
Total non-current liabilities | 3,909,096 | 7,829,765 | 1,115,732 |
TOTAL LIABILITIES | 23,808,715 | 24,089,095 | 3,432,669 |
TOTAL QIFU TECHNOLOGY INC EQUITY | 21,937,483 | 22,839,274 | 3,254,568 |
Noncontrolling interests | 72,374 | 60,146 | 8,571 |
TOTAL EQUITY | 22,009,857 | 22,899,420 | 3,263,139 |
TOTAL LIABILITIES AND EQUITY | 45,818,572 | 46,988,515 | 6,695,808 |
Unaudited Condensed Consolidated Statements of Operations (Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“USD”) except for number of shares and per share data, or otherwise noted) |
|||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||
2023 | 2024 | 2024 | 2023 | 2024 | 2024 | ||||||||
RMB | RMB | USD | RMB | RMB | USD | ||||||||
Credit driven services | 3,070,969 | 2,901,040 | 413,396 | 8,490,297 | 8,829,527 | 1,258,197 | |||||||
Loan facilitation and servicing fees-capital heavy | 479,248 | 258,717 | 36,867 | 1,185,924 | 653,556 | 93,131 | |||||||
Financing income | 1,369,855 | 1,744,075 | 248,529 | 3,624,475 | 4,969,171 | 708,101 | |||||||
Revenue from releasing of guarantee liabilities | 1,165,737 | 794,586 | 113,228 | 3,534,111 | 2,933,190 | 417,976 | |||||||
Other services fees | 56,129 | 103,662 | 14,772 | 145,787 | 273,610 | 38,989 | |||||||
Platform services | 1,210,057 | 1,469,118 | 209,348 | 3,304,227 | 3,853,877 | 549,173 | |||||||
Loan facilitation and servicing fees-capital light | 863,860 | 574,615 | 81,882 | 2,516,970 | 1,601,735 | 228,245 | |||||||
Referral services fees | 234,190 | 763,115 | 108,743 | 503,530 | 1,935,430 | 275,797 | |||||||
Other services fees | 112,007 | 131,388 | 18,723 | 283,727 | 316,712 | 45,131 | |||||||
Total net revenue | 4,281,026 | 4,370,158 | 622,744 | 11,794,524 | 12,683,404 | 1,807,370 | |||||||
Facilitation, origination and servicing | 639,795 | 707,859 | 100,869 | 1,928,125 | 2,166,045 | 308,659 | |||||||
Funding costs | 160,181 | 146,829 | 20,923 | 484,429 | 464,094 | 66,133 | |||||||
Sales and marketing | 529,632 | 419,936 | 59,840 | 1,388,295 | 1,201,941 | 171,275 | |||||||
General and administrative | 95,393 | 91,975 | 13,106 | 313,039 | 293,444 | 41,815 | |||||||
Provision for loans receivable | 508,990 | 477,541 | 68,049 | 1,511,160 | 2,174,970 | 309,931 | |||||||
Provision for financial assets receivable | 86,875 | 64,437 | 9,182 | 237,892 | 233,606 | 33,289 | |||||||
Provision for accounts receivable and contract assets | 39,724 | 108,792 | 15,503 | 84,694 | 344,031 | 49,024 | |||||||
Provision for contingent liabilities | 831,563 | 63,635 | 9,068 | 2,269,487 | 167,032 | 23,802 | |||||||
Total operating costs and expenses | 2,892,153 | 2,081,004 | 296,540 | 8,217,121 | 7,045,163 | 1,003,928 | |||||||
Income from operations | 1,388,873 | 2,289,154 | 326,204 | 3,577,403 | 5,638,241 | 803,442 | |||||||
Interest income, net | 49,713 | 66,019 | 9,408 | 170,337 | 162,064 | 23,094 | |||||||
Foreign exchange (loss) gain | (659 | ) | (1,410 | ) | (201 | ) | 3,171 | (1,168 | ) | (166 | ) | ||
Other income, net | 40,175 | 3,178 | 453 | 225,727 | 160,576 | 22,882 | |||||||
Investment loss | – | – | – | (30,112 | ) | – | – | ||||||
Income before income tax expense | 1,478,102 | 2,356,941 | 335,864 | 3,946,526 | 5,959,713 | 849,252 | |||||||
Income taxes expense | (340,412 | ) | (558,144 | ) | (79,535 | ) | (785,637 | ) | (1,624,264 | ) | (231,456 | ) | |
Net income | 1,137,690 | 1,798,797 | 256,329 | 3,160,889 | 4,335,449 | 617,796 | |||||||
Net loss attributable to noncontrolling interests | 4,357 | 4,065 | 579 | 12,707 | 12,228 | 1,742 | |||||||
Net income attributable to ordinary shareholders of the Company | 1,142,047 | 1,802,862 | 256,908 | 3,173,596 | 4,347,677 | 619,538 | |||||||
Net income per ordinary share attributable to ordinary shareholders of Qifu Technology, Inc. | |||||||||||||
Basic | 3.56 | 6.20 | 0.88 | 9.85 | 14.39 | 2.05 | |||||||
Diluted | 3.47 | 6.09 | 0.87 | 9.61 | 14.11 | 2.01 | |||||||
Net income per ADS attributable to ordinary shareholders of Qifu Technology, Inc. | |||||||||||||
Basic | 7.12 | 12.40 | 1.76 | 19.70 | 28.78 | 4.10 | |||||||
Diluted | 6.94 | 12.18 | 1.74 | 19.22 | 28.22 | 4.02 | |||||||
Weighted average shares used in calculating net income per ordinary share | |||||||||||||
Basic | 320,789,494 | 290,601,938 | 290,601,938 | 322,240,695 | 302,088,098 | 302,088,098 | |||||||
Diluted | 329,220,827 | 296,205,651 | 296,205,651 | 330,391,888 | 308,157,887 | 308,157,887 | |||||||
Unaudited Condensed Consolidated Statements of Cash Flows (Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“USD”) except for number of shares and per share data, or otherwise noted) |
|||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||
2023 | 2024 | 2024 | 2023 | 2024 | 2024 | ||||||||
RMB | RMB | USD | RMB | RMB | USD | ||||||||
Net cash provided by operating activities | 1,243,893 | 2,371,822 | 337,982 | 4,766,559 | 6,291,705 | 896,561 | |||||||
Net cash used in investing activities | (2,260,922 | ) | (2,929,892 | ) | (417,506 | ) | (9,262,095 | ) | (7,048,470 | ) | (1,004,399 | ) | |
Net cash provided by (used in) financing activities | 702,952 | (1,248,749 | ) | (177,945 | ) | 1,978,079 | (240,947 | ) | (34,335 | ) | |||
Effect of foreign exchange rate changes | 4,934 | (23,638 | ) | (3,368 | ) | 10,492 | (19,428 | ) | (2,767 | ) | |||
Net decrease in cash and cash equivalents | (309,143 | ) | (1,830,457 | ) | (260,837 | ) | (2,506,965 | ) | (1,017,140 | ) | (144,940 | ) | |
Cash, cash equivalents, and restricted cash, beginning of period | 8,314,541 | 8,372,314 | 1,193,045 | 10,512,363 | 7,558,997 | 1,077,148 | |||||||
Cash, cash equivalents, and restricted cash, end of period | 8,005,398 | 6,541,857 | 932,208 | 8,005,398 | 6,541,857 | 932,208 | |||||||
Unaudited Condensed Consolidated Statements of Comprehensive (Loss)/Income (Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“USD”) except for number of shares and per share data, or otherwise noted) |
|||||
Three months ended September 30, | |||||
2023 | 2024 | 2024 | |||
RMB | RMB | USD | |||
Net income | 1,137,690 | 1,798,797 | 256,329 | ||
Other comprehensive income, net of tax of nil: | |||||
Foreign currency translation adjustment | 4,051 | (102,976 | ) | (14,674 | ) |
Other comprehensive income (loss) | 4,051 | (102,976 | ) | (14,674 | ) |
Total comprehensive income | 1,141,741 | 1,695,821 | 241,655 | ||
Comprehensive loss attributable to noncontrolling interests | 4,357 | 4,065 | 579 | ||
Comprehensive income attributable to ordinary shareholders | 1,146,098 | 1,699,886 | 242,234 | ||
Nine months ended September 30, | |||||
2023 | 2024 | 2024 | |||
RMB | RMB | USD | |||
Net income | 3,160,889 | 4,335,449 | 617,796 | ||
Other comprehensive income, net of tax of nil: | |||||
Foreign currency translation adjustment | 20,724 | (99,076 | ) | (14,118 | ) |
Other comprehensive income (loss) | 20,724 | (99,076 | ) | (14,118 | ) |
Total comprehensive income | 3,181,613 | 4,236,373 | 603,678 | ||
Comprehensive loss attributable to noncontrolling interests | 12,707 | 12,228 | 1,742 | ||
Comprehensive income attributable to ordinary shareholders | 3,194,320 | 4,248,601 | 605,420 | ||
Unaudited Reconciliations of GAAP and Non-GAAP Results (Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“USD”) except for number of shares and per share data, or otherwise noted) |
|||||
Three months ended September 30, | |||||
2023 | 2024 | 2024 | |||
RMB | RMB | USD | |||
Reconciliation of Non-GAAP Net Income to Net Income | |||||
Net income | 1,137,690 | 1,798,797 | 256,329 | ||
Add: Share-based compensation expenses | 43,289 | 26,339 | 3,753 | ||
Non-GAAP net income | 1,180,979 | 1,825,136 | 260,082 | ||
GAAP net income margin | 26.6 | % | 41.2 | % | |
Non-GAAP net income margin | 27.6 | % | 41.8 | % | |
Net income attributable to shareholders of Qifu Technology, Inc. | 1,142,047 | 1,802,862 | 256,908 | ||
Add: Share-based compensation expenses | 43,289 | 26,339 | 3,753 | ||
Non-GAAP net income attributable to shareholders of Qifu Technology, Inc. | 1,185,336 | 1,829,201 | 260,661 | ||
Weighted average ADS used in calculating net income per ordinary share for both GAAP and non-GAAP EPS – diluted | 164,610,414 | 148,102,826 | 148,102,826 | ||
Net income per ADS attributable to ordinary shareholders of Qifu Technology, Inc. – diluted | 6.94 | 12.18 | 1.74 | ||
Non-GAAP net income per ADS attributable to ordinary shareholders of Qifu Technology, Inc. – diluted | 7.20 | 12.35 | 1.76 | ||
Reconciliation of Non-GAAP Income from operations to Income from operations | |||||
Income from operations | 1,388,873 | 2,289,154 | 326,204 | ||
Add: Share-based compensation expenses | 43,289 | 26,339 | 3,753 | ||
Non-GAAP Income from operations | 1,432,162 | 2,315,493 | 329,957 | ||
GAAP operating margin | 32.4 | % | 52.4 | % | |
Non-GAAP operating margin | 33.5 | % | 53.0 | % | |
Nine months ended September 30, | |||||
2023 | 2024 | 2024 | |||
RMB | RMB | USD | |||
Reconciliation of Non-GAAP Net Income to Net Income | |||||
Net income | 3,160,889 | 4,335,449 | 617,796 | ||
Add: Share-based compensation expenses | 143,032 | 107,893 | 15,375 | ||
Non-GAAP net income | 3,303,921 | 4,443,342 | 633,171 | ||
GAAP net income margin | 26.8 | % | 34.2 | % | |
Non-GAAP net income margin | 28.0 | % | 35.0 | % | |
Net income attributable to shareholders of Qifu Technology, Inc. | 3,173,596 | 4,347,677 | 619,538 | ||
Add: Share-based compensation expenses | 143,032 | 107,893 | 15,375 | ||
Non-GAAP net income attributable to shareholders of Qifu Technology, Inc. | 3,316,628 | 4,455,570 | 634,913 | ||
Weighted average ADS used in calculating net income per ordinary share for both GAAP and non-GAAP EPS – diluted | 165,195,944 | 154,078,944 | 154,078,944 | ||
Net income per ADS attributable to ordinary shareholders of Qifu Technology, Inc. – diluted | 19.22 | 28.22 | 4.02 | ||
Non-GAAP net income per ADS attributable to ordinary shareholders of Qifu Technology, Inc. – diluted | 20.08 | 28.92 | 4.12 | ||
Reconciliation of Non-GAAP Income from operations to Income from operations | |||||
Income from operations | 3,577,403 | 5,638,241 | 803,442 | ||
Add: Share-based compensation expenses | 143,032 | 107,893 | 15,375 | ||
Non-GAAP Income from operations | 3,720,435 | 5,746,134 | 818,817 | ||
GAAP operating margin | 30.3 | % | 44.5 | % | |
Non-GAAP operating margin | 31.5 | % | 45.3 | % |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Duos Technologies Group Reports Improved Third Quarter 2024 Results
JACKSONVILLE, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) — Duos Technologies Group, Inc. (“Duos” or the “Company”) DUOT, reported financial results for the third quarter (“Q3 2024”) ended September 30, 2024.
Third Quarter 2024 and Recent Operational Highlights
- Delivered and installed Edge Data Center for Amtrak at the Secaucus location. Construction work continues at the site. Received more than $1.4 million in contract modifications at Amtrak including renewal of the subscription utilizing three portals for long-distance passenger trains. Initial discussions for future sites in progress.
- Expanded investment in new subsidiary, “Duos Edge AI” with the addition of three new EDCs for a total of six units. Expecting continuous delivery to field in Q4 and Q1 and with initial customer indications of approximately $3.3 million in annual recurring revenue for 2025.
- New subsidiary, “Duos Energy Corporation“, secured initial revenues during the quarter of approximately $500,000 for consulting services to a large private equity group related to the evaluation of power generation assets with additional services expected in Q4. Using our existing in-house expertise to support the massive demand for AI, Edge computing, and 5G rollout this new subsidiary is aligned with our strategy to be an important part of the growth in data centers.
- Over 2.3 million comprehensive railcar scans were performed in the third quarter across 13 portals, with more than 379,000 unique railcars scanned. This metric encompasses all railcars scanned at locations across the U.S., Canada, and Mexico, representing approximately 24% of the total freight car population in North America.
- As of the end of the third quarter, the Company now has $18.8 million of revenue in backlog including near-term extensions. In addition, the Company received a cash exercise of approximately $900,000 for all remaining warrants and the Company now has no warrants outstanding.
Third Quarter 2024 Financial Results
It should be noted that the following Financial Results represent the consolidation of the Company with its subsidiaries Duos Technologies, Inc., Duos Edge AI, Inc., and Duos Energy Corporation.
Total revenues for Q3 2024 increased 112% to $3.24 million compared to $1.53 million in the third quarter of 2023 (“Q3 2023”). Total revenue for Q3 2024 represents an aggregate of approximately $1,685,000 of technology systems revenue and approximately $1,550,000 in recurring services and consulting revenue. The increase in overall revenues is primarily attributed to a $1.4 million contract modification associated with our two high-speed Railcar Inspection Portals project, which was awarded and largely recognized as revenue during Q3 2024. There was an 88% increase in recurring services and consulting revenue for the same comparison period as a result of new AI and subscription customers that were not present in the same quarter last year as well as increases in service contract revenue due to higher service contract prices. The Company also generated $505,982 in services and consulting revenue from power consulting work, which was new to this quarter.
Cost of revenues for Q3 2024 increased 78% to $2.32 million compared to $1.30 million for Q3 2023. The increase in cost of revenues was driven by $473,069 in amortization expenses recorded in 2024 to offset site revenue related to a nonmonetary transaction for the new services and data agreement signed during the second quarter of 2024. The Company also generated $505,982 in services and consulting revenue from power consulting work, which was provided at cost, further increasing the cost of revenue for services and consulting, which was also not present in the corresponding period of 2023.
Gross margin for Q3 2024 increased 306% to $919,000 compared to $226,000 for Q3 2023. The increase in margin was primarily due to the awarded change order, associated with our two high-speed, transit-focused Railcar Inspection Portals, that was awarded and substantially recognized in Q3 2024. This was offset by $505,982 in services and consulting revenue from power consulting work, which was largely provided at cost, which had a onetime dilutive effect on gross margin. These same project revenues and subsequent margin impacts were absent during the third quarter of 2023.
Operating expenses for Q3 2024 decreased 11% to $2.84 million compared to $3.20 million for Q3 2023. The decrease in expenses is attributed to reductions in development and administrative costs due to the completion of certain activities and the impact of previously implemented cost reductions. Stable operating expenses are expected for the remainder of 2024 while we continue to focus on further efficiencies to support anticipated revenue growth. The decrease in operating expenses is slightly offset by additional investments in sales resources for expansion of the commercial team that was made in the latter half of 2023. The Company implemented a 5% reduction in staff in early Q3 2024. Beginning in late Q3 2024, the Company allocated personnel costs, typically recorded under operating expenses, to costs of revenue associated with power consulting efforts, allowing the Company to recover costs that it would not have otherwise.
Net operating loss for Q3 2024 totaled $1.92 million compared to net operating loss of $2.97 million for Q3 2023. Operating losses were lower than the comparative quarter of a year ago. The decrease in loss from operations was primarily the result of higher revenues recorded in the quarter related to the two high-speed RIPs for a passenger transit client accompanied by a planned reduction in expenses which resulted in an overall decrease in operating loss compared to the same quarter in 2023.
Net loss for Q3 2024 totaled $1.40 million compared to net loss of $2.95 million for Q3 2023. The 53% decrease in net loss was mostly attributed to the increase in revenues as described above as well remaining successful in driving down operating costs, a trend which is expected to continue.
Cash and cash equivalents at September 30, 2024 totaled $0.65 million compared to $2.44 million at December 31, 2023. In addition, the Company had over $2.21 million in receivables and contract assets for a total of approximately $2.86 million in cash and expected short-term liquidity.
Nine Month 2024 Financial Results
Total revenue decreased 2% to $5.82 million from $5.95 million in the same period last year. Total revenue for the first nine months of 2024 represents an aggregate of approximately $2.22 million of technology systems revenue and approximately $3.60 million in recurring services and consulting revenue. An increase in recurring revenues by 42% was offset by the decrease in technology systems revenue. The decrease in technology systems revenue is primarily attributed to delays outside of the Company’s control with deployment of our two high-speed Railcar Inspection Portals. The Company was able to contract a change order related to our two high-speed Railcar Inspection Portals project in the third quarter of 2024. This adjustment added more than $1.4 million to the contract’s total value, with a substantial portion recognized in Q3 of 2024. The increase in the services portion of our revenues stems from the addition of new AI and subscription customers that were not present in the same quarter. Last year as well as increases in service contract revenue due to higher service contract prices. We also generated $505,982 in services and consulting revenue from power consulting work, which was new to this quarter.
Cost of revenues increased 2% to $5.02 million from $4.94 million in the same period last year. The increase in cost of revenues was driven by $1,021,190 in amortization expenses recorded in 2024 to offset site revenue related to a nonmonetary transaction for the new services and data agreement signed during the second quarter of 2024. The Company also generated $505,982 in services and consulting revenue from power consulting work, which was provided at cost, further increasing the cost of revenue for services and consulting, which was also not present in the corresponding period of 2023.
Gross margin decreased 21% to $799,000 from $1,005,000 in the same period last year. The decrease in gross margin was a direct result of the timing of business activity related to the manufacturing of two high-speed, transit-focused Railcar Inspection Portals. The revenues from the aforementioned project and subsequent margin impacts were not present during the first and second quarters of 2024. The Company also generated $505,982 in services and consulting revenue from power consulting work, which was provided largely at cost, having a dilutive effect on the overall gross margin. These same project revenues and subsequent margin contributions were absent during the third quarter of 2023.
Operating expenses decreased 6% to $8.70 million from $9.27 million in the same period last year. The Company experienced a slight decrease in overall operating expenses due to reductions in development costs and a decrease in administrative costs, primarily from a reduction in workforce which began in Q3. However, this was partially offset by an increase in sales and marketing expenses, driven by the continued expansion of our commercial team for the new subsidiaries which began in the latter half of 2023 as we prepare to enter new markets. Beginning in late Q3 2024, the Company allocated personnel costs, typically recorded under operating expenses, to costs of revenue associated with power consulting efforts, allowing the Company to recover costs that it would not have otherwise offsetting the impact of certain low margin revenues.
Net operating loss totaled $7.90 million compared to net operating loss of $8.27 million in the same period last year. The decrease in loss from operations was primarily the result of planned decreases in operating expenses, which offset the impact of lower revenues recorded in the period as a consequence of delays in going to field for the two high-speed RIPs for a passenger transit client.
Net loss totaled $7.36 million compared to a net loss of $8.08 million in the same period last year. The decrease in net loss was mostly attributable to the slight decrease in revenues as previously noted above, partially offset by the increase in services and consulting revenue and decrease in operating expenses.
Financial Outlook
At the end of the third quarter, the Company’s contracts in backlog and near-term renewals and extensions are now more than $18.8 million in revenue, of which approximately at least $1.6 million is expected to be recognized during the remainder of 2024. The balance of contract backlog is comprised of multi-year service and software agreements as well as project revenues. It should be noted that $10.0 million of the revenue in backlog is for data access to support the new subscription business and is accounted for as a “non-monetary exchange” that resulted from an amendment to a Master Material and Service Purchase Agreement with a Class 1 railroad. Any new subscription business going forward will be offset by royalty payments by Duos.
The agreement gives Duos the rights to use and resell all data acquired by seven portals owned by the Class I railroad. The initial decrease in cash receivables is expected to be offset from revenues for data subscriptions to owners and lessors of railcar assets for the provision of mechanical and safety data and longer-term provide an expected growing, high-margin, revenue stream from subscribers.
Duos anticipates an improvement in operating results to be reflected over the next 12 months as a result of the new initiatives described in this release and the Company will provide further updates as they become available.
Management Commentary
“The Company has made significant progress this year particularly in the establishment of new businesses and related market opportunities,” said Chuck Ferry, Duos CEO. “I will be discussing more on these expansions in our upcoming earnings call but while the improved results this quarter are encouraging. I am particularly pleased with the progress of our Duos Edge AI subsidiary which continues to make inroads to that market. I expect that Duos will be delivering much higher growth, particularly in 2025 and beyond.”
Conference Call
The Company’s management will host a conference call tomorrow, November 20, 2024, at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) to discuss these results, followed by a question-and-answer period.
Date: Wednesday, November 20, 2024
Time: 4:00 p.m. Eastern time (1:00 p.m. Pacific time)
U.S. dial-in: 877-407-3088
International dial-in: 201-389-0927
Confirmation: 13749773
Please call the conference telephone number 5-10 minutes prior to the start time of the conference call. An operator will register your name and organization.
If you have any difficulty connecting with the conference call, please contact DUOT@duostech.com.
The conference call will be broadcast live via telephone and available for online replay via the investor section of the Company’s website here.
About Duos Technologies Group, Inc.
Duos Technologies Group, Inc. DUOT, based in Jacksonville, Florida, through its wholly owned subsidiaries, Duos Technologies, Inc., Duos Edge AI, Inc., and Duos Energy Corporation, designs, develops, deploys and operates intelligent technology solutions for Machine Vision and Artificial Intelligence (“AI”) applications including real-time analysis of fast-moving vehicles, Edge Data Centers and power consulting. For more information, visit www.duostech.com , www.duosedge.ai and www.duosenergycorp.com.
Forward- Looking Statements
This news release includes forward-looking statements regarding the Company’s financial results and estimates and business prospects that involve substantial risks and uncertainties that could cause actual results to differ materially. Forward-looking statements relate to future events and typically address the Company’s expected future business and financial performance. The forward-looking statements in this news release relate to, among other things, information regarding anticipated timing for the installation, development and delivery dates of our systems; anticipated entry into additional contracts; anticipated effects of macro-economic factors (including effects relating to supply chain disruptions and inflation); timing with respect to revenue recognition; trends in the rate at which our costs increase relative to increases in our revenue; anticipated reductions in costs due to changes in the Company’s organizational structure; potential increases in revenue, including increases in recurring revenue; potential changes in gross margin (including the timing thereof); statements regarding our backlog and potential revenues deriving therefrom; and statements about future profitability and potential growth of the Company. Words such as “believe,” “expect,” “anticipate,” “should,” “plan,” “aim,” “will,” “may,” “should,” “could,” “intend,” “estimate,” “project,” “forecast,” “target,” “potential” and other words and terms of similar meaning, typically identify such forward-looking statements. Forward-looking statements involve risks and uncertainties and there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These factors include, but are not limited to, the Company’s ability to continue as a going concern, the Company’s ability to generate sufficient cash to continue and expand operations, the competitive environment generally and in the Company’s specific market areas, changes in technology, the availability of and the terms of financing, changes in costs and availability of goods and services, economic conditions in general and in the Company’s specific market areas, changes in federal, state and/or local government laws and regulations potentially affecting the use of the Company’s technology, changes in operating strategy or development plans and the ability to attract and retain qualified personnel. The Company cautions that the foregoing list of risks, uncertainties and factors is not exclusive. Additional information concerning these and other risk factors is contained in the Company’s most recently filed Annual Reports on Form 10-K, subsequent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K, and other filings filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”), which are available at the SEC’s website, http://www.sec.gov. The Company believes its plans, intentions and expectations reflected in or suggested by these forward-looking statements are based on reasonable assumptions. No assurance, however, can be given that the Company will achieve or realize these plans, intentions or expectations. Indeed, it is likely that some of the Company’s assumptions may prove to be incorrect. The Company’s actual results and financial position may vary from those projected or implied in the forward-looking statements and the variances may be material. Each forward-looking statement speaks only as of the date of the particular statement. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any forward-looking statement is based, except as required by law. All subsequent written and oral forward-looking statements concerning the Company or other matters attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above.
DUOS TECHNOLOGIES GROUP, INC. AND SUBSIDIARIES | ||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended | |||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
REVENUES: | ||||||||||||||||
Technology systems | $ | 1,686,456 | $ | 705,849 | $ | 2,221,310 | $ | 3,404,107 | ||||||||
Services and consulting | 1,552,454 | 825,074 | 3,598,776 | 2,541,163 | ||||||||||||
Total Revenues | 3,238,910 | 1,530,923 | 5,820,086 | 5,945,270 | ||||||||||||
COST OF REVENUES: | ||||||||||||||||
Technology systems | 947,563 | 883,836 | 2,311,912 | 3,723,151 | ||||||||||||
Services and consulting | 1,372,248 | 420,499 | 2,709,007 | 1,217,022 | ||||||||||||
Total Cost of Revenues | 2,319,811 | 1,304,335 | 5,020,919 | 4,940,173 | ||||||||||||
GROSS MARGIN | 919,099 | 226,588 | 799,167 | 1,005,097 | ||||||||||||
OPERATING EXPENSES: | ||||||||||||||||
Sales and marketing | 471,411 | 353,386 | 1,737,353 | 962,040 | ||||||||||||
Research and development | 396,610 | 450,006 | 1,168,752 | 1,392,692 | ||||||||||||
General and administration | 1,971,358 | 2,394,173 | 5,790,804 | 6,916,390 | ||||||||||||
Total Operating Expenses | 2,839,379 | 3,197,565 | 8,696,909 | 9,271,122 | ||||||||||||
LOSS FROM OPERATIONS | (1,920,280 | ) | (2,970,977 | ) | (7,897,742 | ) | (8,266,025 | ) | ||||||||
OTHER INCOME (EXPENSES): | ||||||||||||||||
Interest expense | (116,396 | ) | (1,406 | ) | (117,991 | ) | (5,816 | ) | ||||||||
Change in fair value of warrant liabilities | 245,980 | – | 245,980 | – | ||||||||||||
Gain on extinguishment of warrant liabilities | 379,626 | – | 379,626 | – | ||||||||||||
Other income, net | 9,407 | 24,647 | 31,984 | 191,022 | ||||||||||||
Total Other Income (Expenses), net | 518,617 | 23,241 | 539,599 | 185,206 | ||||||||||||
NET LOSS | $ | (1,401,663 | ) | $ | (2,947,736 | ) | $ | (7,358,143 | ) | $ | (8,080,819 | ) | ||||
Basic and Diluted Net Loss Per Share | $ | (0.18 | ) | $ | (0.41 | ) | $ | (0.98 | ) | $ | (1.12 | ) | ||||
DUOS TECHNOLOGIES GROUP, INC. AND SUBSIDIARIES | |||||||||
CONSOLIDATED BALANCE SHEETS | |||||||||
September 30, | December 31, | ||||||||
2024 | 2023 | ||||||||
(Unaudited) | |||||||||
ASSETS | |||||||||
CURRENT ASSETS: | |||||||||
Cash | $ | 613,594 | $ | 2,441,842 | |||||
Restricted cash | 32,519 | – | |||||||
Accounts receivable, net | 1,601,152 | 1,462,463 | |||||||
Contract assets | 609,008 | 641,947 | |||||||
Inventory | 1,028,387 | 1,526,165 | |||||||
Prepaid expenses and other current assets | 310,869 | 184,478 | |||||||
Note Receivable, net | 159,375 | – | |||||||
Total Current Assets | 4,354,904 | 6,256,895 | |||||||
Property and equipment, net | 2,318,233 | 726,507 | |||||||
Operating lease right of use asset | 4,117,471 | 4,373,155 | |||||||
Security deposit | 500,000 | 550,000 | |||||||
OTHER ASSETS: | |||||||||
Intangible Asset, net | 10,140,238 | – | |||||||
Note Receivable, net | – | 153,750 | |||||||
Patents and trademarks, net | 128,793 | 129,140 | |||||||
Software development costs, net | 465,228 | 652,838 | |||||||
Total Other Assets | 10,734,259 | 935,728 | |||||||
Total Assets | $ | 22,024,867 | $ | 12,842,285 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
CURRENT LIABILITIES: | |||||||||
Accounts payable | $ | 1,727,190 | $ | 595,634 | |||||
Notes payable – financing agreements | 128,404 | 41,976 | |||||||
Accrued expenses | 323,593 | 164,113 | |||||||
Operating lease obligations-current portion | 793,658 | 779,087 | |||||||
Contract liabilities, current | 2,982,213 | 1,666,243 | |||||||
Total Current Liabilities | 5,955,058 | 3,247,053 | |||||||
Contract liabilities, less current portion | 7,947,755 | – | |||||||
Notes payable | 1,647,995 | – | |||||||
Operating lease obligations, less current portion | 3,961,590 | 4,228,718 | |||||||
Total Liabilities | 19,512,398 | 7,475,771 | |||||||
Commitments and Contingencies (Note 5) | |||||||||
STOCKHOLDERS’ EQUITY: | |||||||||
Preferred stock: $0.001 par value, 10,000,000 authorized, 9,441,000 shares available to be designated | |||||||||
Series A redeemable convertible preferred stock, $10 stated value per share, | – | – | |||||||
500,000 shares designated; 0 and 0 issued and outstanding at September 30, 2024 and December 31, 2023, respectively, | |||||||||
convertible into common stock at $6.30 per share | |||||||||
Series B convertible preferred stock, $1,000 stated value per share, | – | – | |||||||
15,000 shares designated; 0 and 0 issued and outstanding at September 30, 2024 | |||||||||
and December 31, 2023, respectively, convertible into common stock at $7 per share | |||||||||
Series C convertible preferred stock, $1,000 stated value per share, | – | – | |||||||
5,000 shares designated; 0 and 0 issued | |||||||||
and outstanding at September 30, 2024 and December 31, 2023, respectively, | |||||||||
convertible into common stock at $5.50 per share | |||||||||
Series D convertible preferred stock, $1,000 stated value per share, | 1 | 1 | |||||||
4,000 shares designated; 1,399 and 1,299 issued | |||||||||
and outstanding at September30, 2024 and December 31, 2023, respectively, | |||||||||
convertible into common stock at $3.00 per share | |||||||||
Series E convertible preferred stock, $1,000 stated value per share, | |||||||||
30,000 shares designated; 13,625 and 11,500 issued | |||||||||
and outstanding at September 30, 2024 and December 31, 2023, respectively, | 14 | 12 | |||||||
convertible into common stock at $2.61 and $3.00 per share, respectively | |||||||||
Series F convertible preferred stock, $1,000 stated value per share, | |||||||||
5,000 shares designated; 0 and 0 issued | |||||||||
and outstanding at September 30, 2024 and December 31, 2023, respectively, | – | – | |||||||
convertible into common stock at $6.20 per share | |||||||||
Common stock: $0.001 par value; 500,000,000 shares authorized, | |||||||||
8,051,189 and 7,306,663 shares issued, 8,049,865 and 7,305,339 | 8,049 | 7,306 | |||||||
shares outstanding at September 30, 2024 and December 31, 2023, respectively | |||||||||
Additional paid-in-capital | 73,623,552 | 69,120,199 | |||||||
Accumulated deficit | (70,961,695 | ) | (63,603,552 | ) | |||||
Sub-total | 2,669,921 | 5,523,966 | |||||||
Less: Treasury stock (1,324 shares of common stock | |||||||||
at September 30, 2024 and December 31, 2023) | (157,452 | ) | (157,452 | ) | |||||
Total Stockholders’ Equity | 2,512,469 | 5,366,514 | |||||||
Total Liabilities and Stockholders’ Equity | $ | 22,024,867 | $ | 12,842,285 | |||||
DUOS TECHNOLOGIES GROUP, INC. AND SUBSIDIARIES | |||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
(Unaudited) | |||||||
For the Nine Months Ended | |||||||
September 30, | |||||||
2024 | 2023 | ||||||
Cash from operating activities: | |||||||
Net loss | $ | (7,358,143 | ) | $ | (8,080,819 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | 1,472,965 | 393,057 | |||||
Stock based compensation | 281,405 | 499,590 | |||||
Stock issued for services | 122,500 | 105,565 | |||||
Amortization of debt discount related to warrant liability | 73,601 | – | |||||
Fair value of warrant liabilities | (245,980 | ) | – | ||||
Gain on settlement of warrant liabilities | (379,626 | ) | – | ||||
Amortization of operating lease right of use asset | 255,684 | 235,217 | |||||
Changes in assets and liabilities: | |||||||
Accounts receivable | (138,689 | ) | 3,159,389 | ||||
Note receivable | (5,625 | ) | (151,875 | ) | |||
Contract assets | 32,939 | (921,009 | ) | ||||
Inventory | 197,777 | (97,552 | ) | ||||
Security deposit | 50,000 | 50,000 | |||||
Prepaid expenses and other current assets | 300,271 | 543,793 | |||||
Accounts payable | 1,131,552 | (1,670,625 | ) | ||||
Accrued expenses | 159,482 | (178,081 | ) | ||||
Operating lease obligation | (252,557 | ) | (154,653 | ) | |||
Contract liabilities | (1,897,703 | ) | 630,931 | ||||
Net cash used in operating activities | (6,200,147 | ) | (5,637,072 | ) | |||
Cash flows from investing activities: | |||||||
Purchase of patents/trademarks | (8,105 | ) | (58,208 | ) | |||
Purchase of software development | – | (640,609 | ) | ||||
Purchase of fixed assets | (1,547,439 | ) | (199,618 | ) | |||
Net cash used in investing activities | (1,555,544 | ) | (898,435 | ) | |||
Cash flows from financing activities: | |||||||
Repayments on financing agreements | (340,232 | ) | (395,221 | ) | |||
Repayment of finance lease | – | (22,851 | ) | ||||
Proceeds from notes payable | 2,200,000 | – | |||||
Proceeds from warrant exercises | 899,521 | – | |||||
Proceeds from common stock issued | 197,011 | – | |||||
Stock issuance cost | (78,688 | ) | (17,645 | ) | |||
Proceeds from shares issued under Employee Stock Purchase Plan | 87,348 | 117,048 | |||||
Proceeds from preferred stock issued | 2,995,002 | 9,000,000 | |||||
Net cash provided by financing activities | 5,959,962 | 8,681,331 | |||||
Net increase (decrease) in cash | (1,795,729 | ) | 2,145,824 | ||||
Cash, beginning of period | 2,441,842 | 1,121,092 | |||||
Cash, end of period | $ | 646,113 | $ | 3,266,916 | |||
Supplemental Disclosure of Cash Flow Information: | |||||||
Interest paid | $ | 1,596 | $ | 5,816 | |||
Taxes paid | $ | 5,432 | $ | – | |||
Supplemental Non-Cash Investing and Financing Activities: | |||||||
Debt discount for warrant liability | $ | 625,606 | $ | – | |||
Notes issued for financing of insurance premiums | $ | 426,661 | $ | 458,452 | |||
Transfer of inventory to fixed assets | $ | 300,000 | $ | – | |||
Intangible asset acquired with contract liability | $ | 11,161,428 | $ | – | |||
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1cb594bc-763f-4fc8-9a8c-03313c278d6a
This press release was published by a CLEAR® Verified individual.
Contacts
Corporate
Fei Kwong, Director, Corporate Communications
Duos Technologies Group, Inc. DUOT
904-652-1625
fk@duostech.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Unpacking the Latest Options Trading Trends in Moderna
Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna MRNA we detected 37 trades.
If we consider the specifics of each trade, it is accurate to state that 32% of the investors opened trades with bullish expectations and 59% with bearish.
From the overall spotted trades, 19 are puts, for a total amount of $1,152,330 and 18, calls, for a total amount of $1,026,287.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $300.0 for Moderna over the recent three months.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Moderna’s options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Moderna’s significant trades, within a strike price range of $30.0 to $300.0, over the past month.
Moderna Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
MRNA | CALL | SWEEP | BULLISH | 12/20/24 | $3.5 | $3.35 | $3.35 | $40.00 | $169.5K | 1.3K | 1.0K |
MRNA | PUT | TRADE | BULLISH | 06/20/25 | $34.95 | $33.8 | $33.8 | $70.00 | $168.9K | 1.0K | 50 |
MRNA | PUT | SWEEP | BULLISH | 04/17/25 | $24.05 | $24.0 | $24.05 | $60.00 | $137.0K | 1.1K | 59 |
MRNA | CALL | SWEEP | BEARISH | 04/17/25 | $6.3 | $6.2 | $6.21 | $45.00 | $124.0K | 733 | 389 |
MRNA | CALL | SWEEP | BULLISH | 12/20/24 | $3.35 | $3.3 | $3.3 | $40.00 | $113.1K | 1.3K | 344 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm’s mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Having examined the options trading patterns of Moderna, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Current Position of Moderna
- Trading volume stands at 5,807,278, with MRNA’s price down by -4.83%, positioned at $37.6.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 93 days.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge’s Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Surgical Sutures Market Report: Key Insights and Projections | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Nov. 19, 2024 (GLOBE NEWSWIRE) — The surgical suture market is experiencing robust growth, driven by multiple factors. Increasing incidences of chronic diseases, coupled with a rise in the global volume of surgical procedures, are key contributors to this market expansion. Furthermore, the growing adoption of minimally invasive surgical techniques is fueling demand for specialized sutures designed to ensure effective healing and reduced recovery times. As a result, there is a rising demand for innovative sutures that can cater to the evolving needs of modern surgical practices.
Access PDF Sample Report (Including Graphs, Charts & Figures) @
https://exactitudeconsultancy.com/reports/2393/surgical-sutures-market/#request-a-sample
Emerging economies, particularly in Asia-Pacific and Latin America, are playing an increasingly significant role in the market’s expansion due to the development of healthcare infrastructure and an increasing focus on quality healthcare services. This is further compounded by the growing awareness among healthcare professionals regarding the importance of using high-quality sutures to prevent post-surgical complications and improve patient outcomes.
Technological advancements in suture materials, such as bioabsorbable sutures, are driving innovation, while demographic trends, including an aging population, are expected to create sustained demand. As healthcare systems in developing regions continue to modernize and adopt higher standards, the surgical suture market is projected to grow at a compound annual growth rate (CAGR) of approximately 6-8% over the next five years.
However, the market also faces certain challenges. Stringent regulatory requirements and the high cost of compliance present barriers to new entrants, particularly in regions with complex regulatory frameworks. Despite these challenges, the overall outlook for the surgical suture market remains positive, with the continued demand for advanced and specialized sutures driving market opportunities.
Overall, advancements in technology, growing healthcare infrastructure in emerging economies, and demographic trends will continue to shape the growth trajectory of the surgical suture market, with expectations for substantial growth over the coming years.
Market Dynamics
Driver: Rising Surgical Procedures and Trauma Cases
The surgical suture market is experiencing substantial growth, largely driven by the increasing prevalence of chronic diseases and the global rise in surgical procedures. With an aging population and a higher incidence of health conditions such as cardiovascular diseases, diabetes, and cancer, the demand for surgical interventions continues to surge. This uptick is driving the need for effective wound closure solutions, with surgical sutures playing a pivotal role in ensuring proper recovery and minimizing complications.
Simultaneously, ongoing advancements in suture technology have revolutionized the field, enabling the development of advanced suture materials that offer enhanced safety, precision, and efficacy. The continuous improvements in suturing techniques, such as bioabsorbable and smart sutures, have expanded the range of available solutions, making them suitable for various surgical specialties. This technological evolution is expected to further propel market growth as healthcare providers increasingly adopt these innovations to improve patient outcomes. Additionally, the global expansion of healthcare infrastructure, particularly in developing regions, has increased access to surgical care, further contributing to the rising demand for sutures.
Restraint: Availability of Alternative Wound Closure Methods
The increasing adoption of alternative wound closure methods poses a challenge to the traditional surgical suture market. Methods such as surgical staples, tissue adhesives, and hemostats have emerged as viable alternatives, each offering specific advantages for particular types of procedures. Surgical staples, known for their quick application and secure closure, are often preferred for abdominal surgeries and skin closures, where speed is essential. Tissue adhesives, which are less invasive and reduce tissue trauma, are increasingly popular in dermatological and cosmetic surgeries, providing aesthetic benefits. Hemostats, used to control bleeding, are becoming more common in delicate surgeries.
The availability of these alternatives means that surgeons have more options to consider when deciding on the most appropriate wound closure technique for their patients. This diversification in wound closure options is reshaping market dynamics, particularly in procedures where traditional sutures were once the primary choice. As a result, the demand for traditional sutures is experiencing downward pressure in specific surgical segments, prompting a reevaluation of their role in modern wound closure practices.
Opportunity: Growth in Low and Middle-Income Countries
A significant growth opportunity exists in low and middle-income countries (LMICs), where the demand for surgical sutures is expanding due to increasing healthcare spending, improving healthcare infrastructure, and the adoption of advanced surgical techniques. As these regions witness a rise in surgical procedures, particularly minimally invasive surgeries (MIS), there is an increasing demand for specialized sutures designed for these procedures.
Furthermore, with growing awareness and access to quality healthcare, there is a noticeable shift towards more affordable and effective wound closure solutions. Technological innovations, such as biodegradable sutures and smart sutures, present further opportunities to address the unique needs of LMICs, where cost-effective solutions are paramount. These regions also face demographic shifts, such as an aging population, which is likely to increase the incidence of surgeries related to age-related conditions, further driving demand for effective wound closure methods.
Challenge: High Market Competition and Pricing Pressures
The surgical suture market is highly competitive, with numerous manufacturers vying for market share. This intense competition has led to pricing pressures, as healthcare providers increasingly seek affordable solutions without compromising on quality. The need to balance product innovation with cost efficiency is a key challenge for companies operating in this space.
Additionally, the presence of alternative wound closure methods has introduced further pricing pressure, forcing traditional suture manufacturers to reevaluate their pricing strategies. Companies are investing in research and development to differentiate their products through innovation, but this comes with its own set of challenges, particularly in terms of maintaining profitability while meeting the demand for cost-effective solutions. This competitive environment compels manufacturers to focus on operational efficiencies, product quality, and customer value to remain competitive and sustain growth in an evolving market landscape.
Report Link Click Here: https://exactitudeconsultancy.com/reports/2393/surgical-sutures-market/
Suture Thread Segment: A Dominant Market Player
The surgical suture thread segment accounted for a significant share of the surgical sutures market in 2022, driven by the essential role these threads play in wound closure. Surgical sutures are indispensable in a variety of procedures, securing incisions and facilitating healing. The increasing adoption of advanced suture materials has further expanded the range of options available to surgeons, allowing for more precise and effective solutions tailored to specific surgical requirements. As a result, suture threads continue to dominate the market, with growing demand attributed to their ability to support wound healing, minimize infection risks, and ensure successful surgical outcomes. By 2028, this segment is expected to maintain a strong position, supported by ongoing innovations in material technology.
Hospitals Segment: Key End-User
Hospitals represented a major share of the surgical sutures market in 2022, reflecting their central role in delivering a wide range of surgical interventions. The high volume of surgeries performed in hospitals, from routine procedures to complex surgeries, drives the demand for surgical sutures. Hospitals are increasingly adopting advanced suture solutions to improve patient outcomes, reduce complications, and optimize recovery times. This trend is further supported by hospitals’ emphasis on using high-quality, specialized sutures that cater to different types of surgical needs. By 2028, the hospitals segment is expected to remain the largest end-user category, driven by the continuous demand for reliable and effective wound closure solutions across various surgical disciplines.
Cardiovascular Surgeries: A Leading Application Area
In 2022, cardiovascular surgeries accounted for the largest share of the surgical sutures market by application, underlining the critical role sutures play in ensuring the success of intricate cardiovascular procedures. These surgeries require sutures with superior tensile strength, minimal tissue reactivity, and the ability to provide secure closure, making them a crucial part of cardiovascular care. The continued advancements in suture technology, including specialized materials designed for cardiovascular use, are anticipated to drive further growth in this segment. As cardiovascular diseases remain a leading cause of mortality worldwide, the demand for surgical sutures in cardiovascular procedures is projected to maintain its prominence through 2028.
North America dominated the Surgical Sutures Industry in 2022.
In 2022, North America led the surgical sutures market, holding a significant share due to its advanced healthcare infrastructure, robust regulatory environment, and growing awareness of the importance of effective wound care. The region’s established healthcare systems, including hospitals and clinics, have been key drivers of this dominance, with a high number of surgical procedures necessitating the use of surgical sutures.
The regulatory landscape in North America has facilitated the growth of the surgical sutures industry by ensuring the availability of high-quality, safe products. Stringent standards for medical devices, including surgical sutures, help maintain the integrity of patient care, fostering trust and widespread adoption of innovative suture technologies. Additionally, the increasing awareness and focus on patient outcomes and recovery are pushing demand for advanced suture solutions.
The region’s medical professionals are also increasingly emphasizing patient-centered care, which has contributed to a greater focus on effective surgical tools, including sutures, that enhance healing and minimize complications. This trend aligns with the growing shift towards personalized medicine, driving the demand for tailored suture solutions.
With North America’s market dominance in 2022, the region is projected to maintain its lead due to continued advancements in healthcare technologies, expanding surgical procedures, and ongoing efforts to improve healthcare access and patient care quality. Furthermore, the focus on minimizing healthcare costs, coupled with the expansion of minimally invasive surgeries, is likely to contribute to sustained growth in the region’s surgical sutures market.
By 2028, North America’s market share is expected to continue its upward trajectory, driven by these factors and an increasing demand for high-quality, specialized surgical suture products.
Key Players:
- Ethicon, Inc.
- Medtronic Plc
- B. Braun SE
- Healthium MedTech Limited
- Peters Surgical
- Corza Medical
- Aqmen Medtech Pvt. Ltd.
- Futura Surgicare Pvt. Ltd.
- DemeTECH Corporation
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- Smith & Nephew Plc
- CONMED Corporation
- Anchora Medical Ltd.
- Advanced Medical Solutions Group Plc
- Internacional Farmacéutica S.A. de C.V.
- Lotus Surgicals
- Biosintex
- Meril Life Sciences Pvt. Ltd.
- Boston Scientific Corporation
- Mellon Medical B.V.
- Unisur Lifecare Pvt. Ltd.
- Assut Europe
- KatsanKatgüt Sanayi ve Tic. A.S.
- Sutumed Corp.
Market Segmentation:
By Product
- Suture Thread
- Automated Suturing Devices
By Type
- Monofilament Sutures
- Multifilament Sutures
By Application
- Cardiovascular Surgery
- General Surgery
- Gynecological Surgery
- Orthopedic Surgery
- Ophthalmic Surgery
- Cosmetic & Plastic Surgery
- Other Applications
By End User
- Hospitals
- Ambulatory Surgical Centers
- Clinics & Physicians’ Offices
By Region
- North America
- Europe
- Germany
- UK
- Italy
- Spain
- France
- RoE
- Asia Pacific
- Latin America
- Middle East and Africa
Recent Developments
- January 2024 – Medtronic launched its AI-driven platform for digital surgery, Touch Surgery Live Stream, designed to enhance surgical training and execution with real-time analytics for laparoscopic and robotic-assisted surgeries.
- February 2024 – Ethicon, in collaboration with Google Health, introduced a new initiative focused on using AI to improve surgical precision and suturing techniques, aiming to enhance patient outcomes.
- March 2024 – Surgical Innovations released a new range of sutures designed for minimally invasive surgeries, focusing on reducing patient recovery time and improving surgical efficiency.
- April 2024 – Healthium MedTech expanded into Vietnam and Indonesia through partnerships with local hospitals to distribute advanced surgical sutures and wound care products.
Get a Sample PDF Brochure : https://exactitudeconsultancy.com/reports/2393/surgical-sutures-market/#request-a-sample
Related Reports:
Airway Management Devices Market
https://exactitudeconsultancy.com/reports/1131/airway-management-devices-market/
The Global airway management devices market is expected to grow at more than 7.6% CAGR from 2020 to 2028. It is expected to reach above USD 4.03 billion by 2028 from a little above USD 2.10 billion in 2019.
Ligation Devices Market
https://exactitudeconsultancy.com/reports/1171/ligation-devices-market/
The global ligation devices market was valued at $945.8 million in 2020, and is projected to reach $1,681.2 million by 2028, registering a CAGR of 6.2% from 2021 to 2028.
Pet Insurance Market
https://exactitudeconsultancy.com/reports/796/pet-insurance-market/
The Global Pet Insurance Market size is expected to grow at more than 16% CAGR from 2019 to 2026. It is expected to reach above USD 17 billion by 2026 from a little above USD 6 billion in 2019.
Aspiration & Biopsy Needles Market
https://exactitudeconsultancy.com/reports/1400/aspiration-biopsy-needles-market/
The Global Aspiration & Biopsy Needles Market is expected to grow at more than 6.9% CAGR from 2019 to 2028. It is expected to reach above USD 1,699 million by 2028 from a little above USD 932 million in 2019.
Infection Control Market
https://exactitudeconsultancy.com/reports/1119/infection-control-market/
The Global Infection Control Market size is expected to grow at more than 3.5% CAGR from 2019 to 2028. It is expected to reach above USD 56 billion by 2028 from a little above USD 41.5 billion in 2019.
Breast Imaging Market
https://exactitudeconsultancy.com/reports/1441/breast-imaging-market/
The global market of Breast imaging is expected to grow at more than 8.2% CAGR from 2020 to 2028. It is expected to reach above USD 6.76 billion by 2028 from USD 3.6 billion in 2020.
Metal Implants and Medical Alloys Market
https://exactitudeconsultancy.com/reports/1434/metal-implants-and-medical-alloys-market/
The Global metal implants and medical alloys market is expected to grow at an 8.6% CAGR from 2019 to 2028. It is expected to reach above USD 4.4 billion by 2028 from USD 2.3 billion in 2019.
Rehabilitation Equipment Market
https://exactitudeconsultancy.com/reports/1300/rehabilitation-equipment-market/
The global rehabilitation equipment market is expected to grow at 5.20% CAGR from 2019 to 2028. It is expected to reach above USD 19.3 billion by 2028 from USD 12.2 billion in 2019.
Ashwagandha Extracts Market
https://exactitudeconsultancy.com/reports/926/ashwagandha-extracts-market/
The Global Ashwagandha Extracts Market share is expected to grow at more than 36.8% CAGR from 2019 to 2028. It is expected to reach above USD 3.2 billion by 2028 from a little above USD 128 million in 2019.
Electronic Drug Delivery Systems Market
https://exactitudeconsultancy.com/reports/1262/electronic-drug-delivery-systems-market/
The Global Electronic Drug Delivery Systems Market is expected to grow at 8.1% CAGR from 2019 to 2028. It is expected to reach above USD 14.36 million by 2028 from USD 7.50 million in 2019.
Heart Pump Device Market
https://exactitudeconsultancy.com/reports/1173/heart-pump-device-market/
The Global Heart Pump Device Market is expected to grow at more than 21% CAGR from 2020 to 2028. It is expected to reach above USD 7 billion by 2028 from a little above USD 1.6 billion in 2020.
Dental Imaging Market
https://exactitudeconsultancy.com/reports/764/dental-imaging-market/
The Global Dental Imaging Market size is expected to grow at more than 9.5% CAGR from 2016 to 2028. It is expected to reach above USD 5.9 billion by 2028 from a little above USD 2 billion in 2016.
Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@exactitudeconsultancy.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Donna Long Exercises Options, Realizes $237K
Disclosed in a recent SEC filing on November 19, Long, SVP at Dorman Prods DORM, made a noteworthy transaction involving the exercise of company stock options.
What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Long, SVP at Dorman Prods, executed a strategic derivative sale. This involved exercising stock options for 3,277 shares of DORM, resulting in a transaction value of $237,025.
During Tuesday’s morning session, Dorman Prods shares down by 0.0%, currently priced at $134.01. Considering the current price, Long’s 3,277 shares have a total value of $237,025.
All You Need to Know About Dorman Prods
Dorman Products Inc is a supplier of original equipment parts for automobiles. The company produces automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, and HD Solutions through aftermarket retailers, regional and local warehouse distributors, specialty markets, and salvage yards. It operates as a single reportable operating segment, namely, the sale of replacement and upgrades parts in the motor vehicle aftermarket industry, serving passenger cars, light-, medium-, and heavy-duty trucks as well as specialty vehicles. The company operates in the United States.
A Deep Dive into Dorman Prods’s Financials
Revenue Growth: Dorman Prods’s revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 3.19%. This indicates a substantial increase in the company’s top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Key Profitability Indicators:
-
Gross Margin: The company sets a benchmark with a high gross margin of 40.46%, reflecting superior cost management and profitability compared to its peers.
-
Earnings per Share (EPS): Dorman Prods’s EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 1.81.
Debt Management: Dorman Prods’s debt-to-equity ratio is below the industry average at 0.51, reflecting a lower dependency on debt financing and a more conservative financial approach.
Valuation Metrics:
-
Price to Earnings (P/E) Ratio: The P/E ratio of 22.45 is lower than the industry average, implying a discounted valuation for Dorman Prods’s stock.
-
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 2.12 as compared to the industry average, the stock might be considered overvalued based on sales performance.
-
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): At 13.65, the company’s EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company’s future performance.
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Key in Investment Decisions
Insider transactions shouldn’t be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.
In the realm of legality, an “insider” is defined as any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
Breaking Down the Significance of Transaction Codes
Examining transactions, investors often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Dorman Prods’s Insider Trades.
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don’t miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Workhorse Group Reports Third Quarter 2024 Results
CINCINNATI, Nov. 19, 2024 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reported financial results for the third quarter ended September 30, 2024.
Management Commentary
“We continue to make steady progress on several fronts here at Workhorse,” said Company CEO Rick Dauch. “Securing a three-year Master Framework Agreement with FedEx is an extremely important and commercially validating milestone for us as an emerging commercial EV company. We have already built and shipped the first 15 trucks under this agreement and believe we will earn a larger order from FedEx in 2025. We also recently announced several new purchase orders with independent FedEx Ground contractors and are working diligently to convert the positive conversations and vehicle demos we are having with both contractors and other fleets into firm purchase orders.
Mr. Dauch added: “I’m excited to announce that that we have been awarded a General Services Administration (GSA) contract, which further expands our reach by enabling federal government agencies that desire to purchase our vehicles the ability to more easily procure Workhorse vehicles. We continue to see the industry slowly, but steadily, shifting towards zero-emissions, especially in California and other key regions across the country. Workhorse stands ready as a capable and reliable partner to help businesses and government owned fleets execute on their sustainability initiatives.”
Executing Strategic and Financial Actions
- Creating Strong Partnerships with Commercial Last-Mile Delivery Customers: In July, Workhorse and FedEx signed a three-year Master Framework Agreement, and FedEx placed an initial order for 15 W56 step vans, which were delivered for upfit during the third quarter. Following the FedEx Forward Service Provider Summit event in early October, the Company received purchase orders for seven additional W56 electric step vans, which are expected to be delivered in the fourth quarter for completion of third-party upfit. Workhorse continues to experience increased parcel delivery fleet interest, with multiple demos planned in California and additional units in the quoting process.
- Advancing EV Product Roadmap with Extended Product Offerings: The Company’s 208-inch extended wheelbase version of the all-electric W56 step van was certified to meet full FMVSS (Federal Motor Vehicle Safety Standards) and received HVIP (Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project) certification. The 208-inch version extends Workhorse’s product offering to meet larger cargo-volume requirements, while providing the same efficient and robust platform as the 178-inch version. For customers interested in a reduced range option, Workhorse is currently designing and validating a 140-kWh battery option for the W56 chassis which will have a range of 100 miles per charge.
- Establishing Government and Cooperative Purchasing Partnerships: Last week, Workhorse was awarded a General Services Administration (GSA) Multiple Award Schedule (MAS) contract. This milestone allows federal government agencies to streamline procurement of Workhorse vehicles. This award follows a comprehensive review of the Company’s capabilities and inspection of its manufacturing facility, underscoring the quality and reliability of the Company’s processes and products. With the addition of GSA, Workhorse is now an approved supplier under multiple cooperative purchasing agreements, including Sourcewell and the Florida Sheriff’s Association Purchasing Program, which supports police departments, municipalities, and educational institutions across the United States. In addition, the Company’s vehicles are available through OMNIA Partners via its dealer, Doering Fleet Management, and the Company anticipates adding Canoe, Sourcewell’s Canadian counterpart, upon completing pending certifications for Canadian vehicle sales. These partnerships reinforce the Company’s commitment to expanding access to reliable, zero-emission trucks for public sector fleets across North America.
- Conserving Cash and Extending Financial Runway: Workhorse continues to take steps to manage costs across the organization and strengthen its financial position. During the third quarter, the Company began realizing the benefits of cost- and cash-saving measures taken during the first and second quarters to improve its liquidity and working capital requirements. The Company also received additional proceeds in the third quarter from the financing agreement entered into on March 15, 2024.
- Showcasing Reliability, Durability, and Real-World Capabilities on the Road: During a delivery route testing with FedEx Express, the W56 achieved an impressive 31 MPGe (miles per gallon equivalent), compared to the national average fuel economy of 7 MPG for internal combustion engine delivery trucks. The test demonstrated the W56’s significantly lower energy consumption per mile and reduced operating costs for fleet operators, aligning with Workhorse’s own field data. The recent 1,000-mile drive by the W56 to the FedEx Forward event in Orlando, Florida, averaging 27 MPGe in adverse weather conditions showcased the reliability, real-world durability, and performance of the step-van. Based on extensive cost data collected during 12-18 months of daily operations at Stables by Workhorse (the Company’s owned and operated FedEx Ground contractor business), the investment in EV step vans has an expected payback of less than five years, without factoring in any state level incentives.
Third Quarter Financial Results
Sales, net of returns and allowances, for the third quarter of 2024 and 2023 were $2.5 million and $3.0 million, respectively. The decrease in sales was primarily due to the non-recurrence of a $2.3 million sales allowance reversal related to W4 CC vehicle sales recognized in the prior period and an increase in W4 CC and W56 truck sales in the current period of $1.8 million.
Cost of sales was $6.6 million in the third quarter compared to $6.6 million in the same period last year. Cost of sales was primarily flat as increased costs related to direct materials due to higher sales volume were offset by lower inventory reserves of $1.1 million and lower direct and indirect labor costs of $1.0 million primarily due to lower headcount as a result of employee furloughs during the period.
Selling, general, and administrative (“SG&A”) expenses decreased to $7.7 million in the third quarter compared to $11.8 million in the same period last year. The decrease in SG&A expenses was primarily driven by a $1.8 million reduction in employee compensation and related expenses due to lower headcount, a decrease of $1.1 million in consulting expenses, a $0.3 million decrease in legal and professional expenses, and lower corporate insurances of $0.3 million.
Research and development (“R&D”) expenses decreased to $2.3 million in the third quarter compared to $5.8 million in the same period last year. The decrease in R&D expenses was primarily driven by a $2.1 million decrease in employee compensation and related expenses due to lower headcount and a $0.8 million reduction in consulting expenses.
Net interest expense for the third quarter of 2024 was $8.3 million compared to net interest income of $0.4 million for the same period last year. The increase was primarily due to a $5.3 million fair value net loss on note conversions and $2.9 million in financing fees related to funds received.
Net loss was $25.1 million compared to $30.6 million in the same period last year.
As of September 30, 2024, the Company had $3.2 million in cash and cash equivalents, total receivables of $3.7 million, net inventory of $43.2 million, and accounts payable of $10.5 million.
Third Quarter Financial Overview
“We continue to take steps to extend our operational runway and manage our cash flow efficiently through reducing operating costs and improving our liquidity and working capital requirements,” said Workhorse CFO Bob Ginnan. “We are confident in our ability to generate additional purchase orders and revenue from our customers while strengthening our financial position.”
Conference Call
Workhorse management will hold a conference call today, November 14, 2024 at 6:00 p.m. Eastern time (3:00 p.m. Pacific time) to discuss these results and answer related questions.
U.S. dial-in: 877-407-8289
International dial-in: 201-689-8341
Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 949-574-3860.
The conference call will be broadcast live and available for replay here and via the Investor Relations section of Workhorse’s website.
A telephonic replay of the conference call will be available through November 26, 2024.
Toll-free replay number: 877-660-6853
International replay number: 201-612-7415
Replay ID: 13749999
About Workhorse Group Inc.
Workhorse is a technology company focused on providing ground-based electric vehicles to the last-mile delivery sector. As an American original equipment manufacturer, we design and build high performance, battery-electric trucks. Workhorse also develops cloud-based, real-time telematics performance monitoring systems that are fully integrated with our vehicles and enable fleet operators to optimize energy and route efficiency. All Workhorse vehicles are designed to make the movement of people and goods more efficient and less harmful to the environment. For additional information visit workhorse.com.
Forward-Looking Statements
The discussions in this press release contain forward-looking statements reflecting our current expectations that involve risks and uncertainties. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. When used in this presentation, the words “anticipate,” “expect,” “plan,” “believe,” “seek,” “estimate” and similar expressions are intended to identify forward-looking statements. These are statements that relate to future periods and include, but are not limited to, statements about the features, benefits and performance of our products, our ability to introduce new product offerings and increase revenue from existing products, expected expenses including those related to selling and marketing, product development and general and administrative, our beliefs regarding the health and growth of the market for our products, anticipated increase in our customer base, expansion of our products functionalities, expected revenue levels and sources of revenue, expected impact, if any, of legal proceedings, the adequacy of liquidity and capital resources, and expected growth in business. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained in this presentation. Factors that could cause actual results to differ materially include, but are not limited to: our ability to develop and manufacture our new product portfolio, including the W4 CC, W750, W56 and WNext platforms; our ability to attract and retain customers for our existing and new products; the possible implementation of changes to the existing tariff regime by the incoming presidential administration; risks associated with obtaining orders and executing upon such orders; supply chain disruptions, including constraints on steel, semiconductors and other material inputs and resulting cost increases impacting our company, our customers, our suppliers or the industry; our ability to capitalize on opportunities to deliver products to meet customer requirements; our limited operations and need to expand and enhance elements of our production process to fulfill product orders; the ability to protect our intellectual property; market acceptance for our products; our ability to control our expenses; potential competition, including without limitation shifts in technology; volatility in and deterioration of national and international capital markets and economic conditions; global and local business conditions; acts of war (including without limitation the conflicts in Ukraine and Israel) and/or terrorism; the prices being charged by our competitors; our inability to retain key members of our management team; our inability to raise additional capital to fund our operations and business plan; our ability to regain compliance with the listing requirements of the Nasdaq Capital Market and otherwise maintain the listing of our securities thereon and the impact of any steps to regain such compliance; our inability to satisfy our customer warranty claims; the outcome of any regulatory or legal proceedings, including with Coulomb Solutions, Inc.; our ability to consummate and realize the benefits of a potential sale and leaseback transaction of our Union City facility; and our liquidity and other risks and uncertainties and other factors discussed from time to time in our filings with the Securities and Exchange Commission (“SEC”), including our annual report on Form 10-K filed with the SEC. Forward-looking statements speak only as of the date hereof. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Media Contact:
Aaron Palash / Greg Klassen
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449
Investor Relations Contact:
Tom Colton and Greg Bradbury
Gateway Group
949-574-3860
WKHS@gateway-grp.com
Workhorse Group Inc. Condensed Consolidated Balance Sheets (Unaudited) |
|||||||
September 30, 2024 |
December 31, 2023 |
||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 3,244,806 | $ | 25,845,915 | |||
Restricted cash | — | 10,000,000 | |||||
Accounts receivable, less allowance for credit losses of $0.2 and $0.2 million as of September 30, 2024 and December 31, 2023, respectively | 682,673 | 2,326,774 | |||||
Other receivables | 3,002,143 | 2,143,435 | |||||
Inventory, net | 43,186,462 | 45,408,192 | |||||
Prepaid expenses and other current assets | 7,357,838 | 8,101,162 | |||||
Total current assets | 57,473,922 | 93,825,478 | |||||
Property, plant and equipment, net | 34,825,810 | 37,876,955 | |||||
Operating lease right-of-use assets, net | 3,465,637 | 4,174,800 | |||||
Finance lease right-of-use assets, net | 5,470,933 | 5,621,181 | |||||
Other assets | 176,310 | 176,310 | |||||
Total Assets | $ | 101,412,612 | $ | 141,674,724 | |||
Liabilities | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 10,572,525 | $ | 12,456,272 | |||
Accrued and other current liabilities | 8,384,321 | 4,862,740 | |||||
Deferred revenue | 6,350,581 | 4,714,331 | |||||
Warranty liability | 776,423 | 1,902,647 | |||||
Operating lease liabilities, current | 1,001,120 | 1,012,428 | |||||
Finance lease liabilities, current | 2,100,635 | 2,548,184 | |||||
Warrant liability | 7,229,919 | 5,605,325 | |||||
Current portion of convertible notes | 13,182,467 | 20,180,100 | |||||
Total current liabilities | 49,597,991 | 53,282,027 | |||||
Operating lease liabilities, long-term | 4,556,738 | 5,280,526 | |||||
Total Liabilities | 54,154,729 | 58,562,553 | |||||
Commitments and contingencies | |||||||
Stockholders’ Equity: | |||||||
Common stock, par value $0.001 per share, 450,000,000 shares authorized, 31,862,091 shares issued and outstanding as of September 30, 2024 and 14,299,042 shares issued and outstanding as of December 31, 2023 (presented on a reverse stock split-adjusted basis) |
31,862 | 14,299 | |||||
Additional paid-in capital | 879,405,617 | 834,666,123 | |||||
Accumulated deficit | (832,179,596 | ) | (751,568,251 | ) | |||
Total stockholders’ equity | 47,257,883 | 83,112,171 | |||||
Total Liabilities and Stockholders’ Equity | $ | 101,412,612 | $ | 141,674,724 | |||
Workhorse Group Inc. Condensed Consolidated Statements of Operations (Unaudited) |
|||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Sales, net of returns and allowances | $ | 2,509,717 | $ | 3,028,545 | $ | 4,691,451 | $ | 8,688,423 | |||||||
Cost of sales | 6,642,549 | 6,557,358 | 21,386,676 | 20,312,854 | |||||||||||
Gross loss | (4,132,832 | ) | (3,528,813 | ) | (16,695,225 | ) | (11,624,431 | ) | |||||||
Operating expenses | |||||||||||||||
Selling, general and administrative | 7,722,014 | 11,756,291 | 33,883,845 | 40,448,651 | |||||||||||
Research and development | 2,313,423 | 5,771,588 | 7,834,113 | 18,056,182 | |||||||||||
Total operating expenses | 10,035,437 | 17,527,879 | 41,717,958 | 58,504,833 | |||||||||||
Loss from operations | (14,168,269 | ) | (21,056,692 | ) | (58,413,183 | ) | (70,129,264 | ) | |||||||
Interest income (expense), net | (8,317,813 | ) | 410,980 | (15,109,136 | ) | 1,466,839 | |||||||||
Fair value adjustment (loss) on warrants | (2,649,477 | ) | — | (7,089,027 | ) | — | |||||||||
Other income (loss) | — | (10,000,000 | ) | — | (10,000,000 | ) | |||||||||
Loss before benefit for income taxes | (25,135,559 | ) | (30,645,712 | ) | (80,611,346 | ) | (78,662,425 | ) | |||||||
Benefit for income taxes | — | — | — | — | |||||||||||
Net loss | $ | (25,135,559 | ) | $ | (30,645,712 | ) | $ | (80,611,346 | ) | $ | (78,662,425 | ) | |||
Net loss per share of common stock | |||||||||||||||
Basic and Diluted | $ | (0.98 | ) | $ | (2.84 | ) | $ | (4.06 | ) | $ | (8.29 | ) | |||
Weighted average shares used in computing net loss per share of common stock | |||||||||||||||
Basic and Diluted | 25,589,725 | 10,793,926 | 19,879,290 | 9,487,842 | |||||||||||
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Chipotle Mexican Grill's Options: A Look at What the Big Money is Thinking
Deep-pocketed investors have adopted a bullish approach towards Chipotle Mexican Grill CMG, and it’s something market players shouldn’t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CMG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga’s options scanner highlighted 13 extraordinary options activities for Chipotle Mexican Grill. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 76% leaning bullish and 15% bearish. Among these notable options, 2 are puts, totaling $346,912, and 11 are calls, amounting to $1,090,010.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it’s evident that the major market movers are focusing on a price band between $46.0 and $72.0 for Chipotle Mexican Grill, spanning the last three months.
Insights into Volume & Open Interest
In today’s trading context, the average open interest for options of Chipotle Mexican Grill stands at 905.88, with a total volume reaching 9,383.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Chipotle Mexican Grill, situated within the strike price corridor from $46.0 to $72.0, throughout the last 30 days.
Chipotle Mexican Grill Option Volume And Open Interest Over Last 30 Days
Noteworthy Options Activity:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
CMG | CALL | SWEEP | BULLISH | 01/16/26 | $17.4 | $16.7 | $17.4 | $46.00 | $631.6K | 970 | 706 |
CMG | PUT | SWEEP | BULLISH | 01/16/26 | $14.6 | $14.3 | $14.3 | $72.00 | $318.9K | 57 | 224 |
CMG | CALL | SWEEP | BULLISH | 01/16/26 | $17.5 | $16.7 | $17.4 | $46.00 | $83.5K | 970 | 772 |
CMG | CALL | SWEEP | BEARISH | 01/15/27 | $13.3 | $12.8 | $12.8 | $60.00 | $64.0K | 500 | 11 |
CMG | CALL | TRADE | NEUTRAL | 01/15/27 | $15.6 | $15.2 | $15.42 | $55.00 | $61.6K | 127 | 62 |
About Chipotle Mexican Grill
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $9.9 billion in 2023. The Mexican concept is almost exclusively company-owned, with just two license stores opearted through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of nearly 3,440 stores at the end of 2023, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Having examined the options trading patterns of Chipotle Mexican Grill, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Chipotle Mexican Grill Standing Right Now?
- With a trading volume of 6,291,565, the price of CMG is down by -0.07%, reaching $58.77.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 77 days from now.
What The Experts Say On Chipotle Mexican Grill
5 market experts have recently issued ratings for this stock, with a consensus target price of $63.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* An analyst from BMO Capital persists with their Market Perform rating on Chipotle Mexican Grill, maintaining a target price of $56.
* An analyst from Stephens & Co. persists with their Equal-Weight rating on Chipotle Mexican Grill, maintaining a target price of $65.
* An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $70.
* Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Chipotle Mexican Grill with a target price of $67.
* Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Chipotle Mexican Grill, targeting a price of $60.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chipotle Mexican Grill options trades with real-time alerts from Benzinga Pro.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services
President-elect Donald J. Trump announced on Tuesday afternoon that he will nominate TV personality Dr. Mehmet Oz to serve as the administrator of the Centers for Medicare and Medicaid Services (CMS). The appointment is among a string of TV hosts — mostly from Fox News — to be chosen to join Trump’s cabinet.
In a statement, Trump said the celebrity TV host will “work closely with Robert F. Kennedy Jr. to take on the illness industrial complex.”
Though a household name due to his long-running “The Dr. Oz Show” (2009-2022), Oz got into politics when he unsuccessfully ran for Senate against now Sen. John Fetterman (D-Penn.) in 2022, during which time the good doctor seemed to forge an alliance with Trump.
At the time, Scientific American wrote Dr. Oz should not be a senator or a doctor, noting that his misinformation had already tarnished medicine and would do much worse in the halls of Congress. “Dr. Oz has long pushed misleading, science-free and unproven alternative therapies such as homeopathy, as well as fad diets, detoxes and cleanses.”
News outlets are quick to point out that Dr. Oz has no experience running a large government body like the CMS but that seems to not matter because, according to the President-elect.
“There may be no Physician more qualified and capable than Dr. Oz to Make America Healthy Again,” Trump said in a statement, referring to the words of Robert Kennedy Jr. who will, if confirmed run the Dept. of Health and Human Services.
Read Also: Trump Wants Matt Gaetz Confirmed ‘100%,’ So Does The Cannabis Industry
The multimillionaire TV host initially called cannabis a “mixed bag for easing pain.” But a recent discussion with Michael Roizen, M.D., of the Wellness Institute at the Cleveland Clinic, Dr. Oz said, “Our advice: If your physician recommends it to manage pain, especially if you’re 65 and older, give it a try.”
While Dr. Oz cautions against cannabis consumption for recreational purposes, he said he believes marijuana for pain represents a “safer solution than, for example, narcotics in many cases.”
During his Senate race, Dr. Oz often criticized Fetterman’s support for cannabis legalization though several years earlier he himself referred to cannabis as “one of the most underused tools in America” and that the U.S. should “completely change our policy on marijuana.”
Now Read:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.
MCAN MORTGAGE CORPORATION ANNOUNCES THE DEPARTURE OF ITS PRESIDENT AND CEO AND THE APPOINTMENT OF INTERIM CEO
Stock market symbol
TSX: MKP
TORONTO, Nov. 19, 2024 /CNW/ – MCAN Mortgage Corporation (“MCAN” or the “Company“) announces the departure of Mr. Donald Coulter as President, CEO and director of MCAN. The Board of Directors (the “Board“) would like to express its gratitude to Mr. Coulter for his contribution to MCAN.
The Board is pleased to announce that Mr. Derek Sutherland has been appointed Interim CEO of MCAN until such time as a permanent successor is appointed. Mr. Sutherland is the current Chair of MCAN, has been a director of MCAN since 2017, and has held various positions with MCAN throughout the years including as its Interim CEO in 2023. Ms. Gaelen Morphet has been appointed Lead Director to ensure independent governance at the Board during Mr. Sutherland’s tenure as Interim CEO.
Mr. Sutherland commented, ” I am excited to work along side our talented and dedicated team to ensure continued strong performance and achievement of our objectives, which remains to be a focus on our core mission of providing sustainable growth and returns to our shareholders.”
The Board will be considering options for selecting an individual to permanently fill the CEO role.
MCAN Mortgage Corporation d/b/a MCAN Financial Group (“MCAN” or “we”) is a public company listed on the Toronto Stock Exchange under the symbol MKP and is a reporting issuer in all provinces and territories in Canada. MCAN also qualifies as a mortgage investment corporation (“MIC”) under the Income Tax Act (Canada) (the “Tax Act”).
MCAN’s primary objective is to generate a reliable stream of income by investing in a diversified portfolio of Canadian mortgages, including residential, residential construction, non- residential construction and commercial loans, as well as other types of securities, loans and real estate investments. MCAN employs leverage by issuing term deposits that are eligible for Canada Deposit Insurance Corporation deposit insurance that are sourced through a network of independent financial agents. We manage our capital and asset balances based on the regulations and limits of both the Tax Act and the Office of the Superintendent of Financial Institutions Canada (“OSFI”).
As a MIC, we are entitled to deduct the dividends that we pay to shareholders from our taxable income. Regular dividends are treated as interest income to shareholders for income tax purposes. We are also able to pay capital gains dividends, which would be treated as capital gains to shareholders for income tax purposes. Dividends paid to foreign investors may be subject to withholding taxes. To meet the MIC criteria, 67% of our non-consolidated assets measured on a tax basis are required to be held in cash or cash equivalents and residential mortgages.
MCAN’s wholly owned subsidiary, MCAN Home Mortgage Corporation, is an originator of residential mortgage products across Canada.
A Caution About Forward-looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information can be identified by words such as: “expect”, “intend,” “plan,” “seek,” “believe,” “estimate,” “future,” “likely,” “may,” “should,” “will” and similar forward-looking language. Future prospects of MCAN constitutes forward-looking information. The forward-looking information contained in this news release is based on a number of assumptions which we believe to be reasonable, including assumptions relating to the investment opportunities that will be available to MCAN in its core business. Forward-looking information entails various risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking information. Risks that could cause actual results to differ materially from those expressed or implied in the forward-looking information contained in this press release include, but are not limited to, general risks relating to capital markets, economic conditions, regulatory changes, as well as the operations of our business. These factors may cause actual results to differ materially from those expressed or implied in such forward-looking information. Forward-looking information is not a guarantee of future performance, and management’s assumptions upon which such forward-looking information are based may prove to be incorrect. Investors are cautioned not to place undue reliance on any forward-looking information contained herein. The Company disclaims any obligation to update or revise any forward-looking information contained in this news release, whether as a result of new information, future events or otherwise, except to the extent required by law.
Website: www.mcanfinancial.com
SOURCE MCAN Mortgage Corporation
View original content: http://www.newswire.ca/en/releases/archive/November2024/19/c6571.html
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Insider Activity Update: Manesh Dadlani Executes Options Exercise, Resulting In $409K At Tapestry
Disclosed in a recent SEC filing on November 18, Dadlani, VP at Tapestry TPR, made a noteworthy transaction involving the exercise of company stock options.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Dadlani, VP at Tapestry, a company in the Consumer Discretionary sector, just exercised stock options worth 11,262 shares of TPR stock with an exercise price of $19.03.
The Tuesday morning market activity shows Tapestry shares down by 2.02%, trading at $55.41. This implies a total value of $409,759 for Dadlani’s 11,262 shares.
About Tapestry
Coach, Kate Spade, and Stuart Weitzman are Tapestry’s fashion and accessory brands. The firm’s products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (64% of fiscal 2024 sales), Europe, Asia (29% of fiscal 2024 sales), and elsewhere. Coach (76% of fiscal 2024 sales) is best known for affordable luxury leather products. Kate Spade (20% of fiscal 2023 sales) is known for colorful patterns and graphics. Women’s handbags and accessories produced 69% of Tapestry’s sales in fiscal 2024. Stuart Weitzman (4% of sales) generates virtually all its revenue from women’s footwear.
Tapestry: Financial Performance Dissected
Negative Revenue Trend: Examining Tapestry’s financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -0.38% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Profitability Metrics:
-
Gross Margin: Achieving a high gross margin of 75.28%, the company performs well in terms of cost management and profitability within its sector.
-
Earnings per Share (EPS): Tapestry’s EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.81.
Debt Management: Tapestry’s debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.95, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Understanding Financial Valuation:
-
Price to Earnings (P/E) Ratio: The P/E ratio of 16.39 is lower than the industry average, implying a discounted valuation for Tapestry’s stock.
-
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 1.99, Tapestry’s stock is perceived as being overvalued in the market, particularly in relation to sales performance.
-
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an EV/EBITDA ratio lower than industry averages at 10.73, Tapestry could be considered undervalued.
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Unmasking the Significance of Insider Transactions
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Within the legal framework, an “insider” is defined as any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
Unlocking the Meaning of Transaction Codes
For investors, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Tapestry’s Insider Trades.
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don’t miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.